SlideShare a Scribd company logo
1 of 35
Download to read offline
Part 12: Cardiac Arrest in Special Situations : 2010 American Heart Association
Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular
                                        Care
  Terry L. Vanden Hoek, Laurie J. Morrison, Michael Shuster, Michael Donnino,
    Elizabeth Sinz, Eric J. Lavonas, Farida M. Jeejeebhoy and Andrea Gabrielli


                            Circulation 2010, 122:S829-S861
                     doi: 10.1161/CIRCULATIONAHA.110.971069
  Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX
                                              72514
 Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online
                                         ISSN: 1524-4539




  The online version of this article, along with updated information and services, is
                          located on the World Wide Web at:
              http://circ.ahajournals.org/content/122/18_suppl_3/S829


       An erratum has been published regarding this article. Please see the attached page for:
                                   http://circ.ahajournals.org/




 Subscriptions: Information about subscribing to Circulation is online at
 http://circ.ahajournals.org//subscriptions/

 Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters
 Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Fax:
 410-528-8550. E-mail:
 journalpermissions@lww.com

 Reprints: Information about reprints can be found online at
 http://www.lww.com/reprints




       Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
Part 12: Cardiac Arrest in Special Situations
         2010 American Heart Association Guidelines for Cardiopulmonary
                Resuscitation and Emergency Cardiovascular Care
 Terry L. Vanden Hoek, Chair; Laurie J. Morrison; Michael Shuster; Michael Donnino; Elizabeth Sinz;
                     Eric J. Lavonas; Farida M. Jeejeebhoy; Andrea Gabrielli


T    his section of the 2010 AHA Guidelines for CPR and
     ECC addresses cardiac arrest in situations that require
special treatments or procedures beyond those provided
                                                                              Pathophysiology
                                                                              The pathophysiology of asthma consists of 3 key abnormalities:

                                                                              ●   Bronchoconstriction
during basic life support (BLS) and advanced cardiovas-
                                                                              ●   Airway inflammation
cular life support (ACLS). We have included 15 specific
cardiac arrest situations. The first several sections discuss                 ●   Mucous plugging
cardiac arrest associated with internal physiological or
                                                                                 Complications of severe asthma, such as tension pneumo-
metabolic conditions, such as asthma (12.1), anaphylaxis
                                                                              thorax, lobar atelectasis, pneumonia, and pulmonary edema,
(12.2), pregnancy (12.3), morbid obesity (12.4), pulmo-
                                                                              can contribute to fatalities. Severe asthma exacerbations are
nary embolism (PE) (12.5), and electrolyte imbalance
                                                                              commonly associated with hypercarbia and acidemia, hypo-
(12.6).
                                                                              tension due to decreased venous return, and depressed mental
  The next several sections relate to resuscitation and treat-
                                                                              status, but the most common cause of death is asphyxia.
ment of cardiac arrest associated with external or environ-
mentally related circumstances, such as ingestion of toxic                    Cardiac causes of death are less common.4
substances (12.7), trauma (12.8), accidental hypothermia
(12.9), avalanche (12.10), drowning (12.11), and electric                     Clinical Aspects of Severe Asthma
shock/lightning strikes (12.12).                                              Wheezing is a common physical finding, although the sever-
  The last 3 sections review management of cardiac arrest                     ity of wheezing does not correlate with the degree of airway
that may occur during special situations affecting the heart,                 obstruction. The absence of wheezing may indicate critical
including percutaneous coronary intervention (PCI) (12.13),                   airway obstruction, whereas increased wheezing may indicate
cardiac tamponade (12.14), and cardiac surgery (12.15).                       a positive response to bronchodilator therapy.
                                                                                 Oxygen saturation (SaO2) levels may not reflect progressive
         Part 12.1: Cardiac Arrest Associated                                 alveolar hypoventilation, particularly if oxygen is being admin-
                     With Asthma                                              istered. Note that SaO2 may fall initially during therapy because
Asthma is responsible for more than 2 million visits to the                     2-agonists produce both bronchodilation and vasodilation and
emergency department (ED) in the United States each year,                     initially may increase intrapulmonary shunting.
with 1 in 4 patients requiring admission to a hospital.1                         Other causes of wheezing are pulmonary edema,5 chronic
Annually there are 5,000 to 6,000 asthma-related deaths in                    obstructive pulmonary disease (COPD), pneumonia, anaphyl-
the United States, many occurring in the prehospital                          axis,6 foreign bodies, PE, bronchiectasis, and subglottic mass.7
setting.2 Severe asthma accounts for approximately 2% to
20% of admissions to intensive care units, with up to one
                                                                              Initial Stabilization
third of these patients requiring intubation and mechanical
                                                                              Patients with severe life-threatening asthma require urgent
ventilation.3 This section focuses on the evaluation and
                                                                              and aggressive treatment with simultaneous administration of
treatment of patients with near-fatal asthma.
                                                                              oxygen, bronchodilators, and steroids. Healthcare providers
   Several consensus groups have developed excellent guide-
                                                                              must monitor these patients closely for deterioration. Al-
lines for the management of asthma that are available on the
World Wide Web:                                                               though the pathophysiology of life-threatening asthma con-
                                                                              sists of bronchoconstriction, inflammation, and mucous plug-
●   http://www.nhlbi.nih.gov/about/naepp                                      ging, only bronchoconstriction and inflammation are
●   http://www.ginasthma.com                                                  amenable to drug treatment.


   The American Heart Association requests that this document be cited as follows: Vanden Hoek TL, Morrison LJ, Shuster M, Donnino M, Sinz E,
Lavonas EJ, Jeejeebhoy FM, Gabrielli A. Part 12: cardiac arrest in special situations: 2010 American Heart Association guidelines for cardiopulmonary
resuscitation and emergency cardiovascular care. Circulation. 2010;122(suppl 3):S829 –S861.
   (Circulation. 2010;122[suppl 3]:S829 –S861.)
   © 2010 American Heart Association, Inc.
    Circulation is available at http://circ.ahajournals.org                                        DOI: 10.1161/CIRCULATIONAHA.110.971069

                       Downloaded from http://circ.ahajournals.org/S829 MED CTR BOISE on September 29, 2011
                                                                    at VA
S830       Circulation        November 2, 2010


Primary Therapy                                                       minutes and no systemic side effects. The drug is typically given
Oxygen                                                                only once because of its prolonged onset of action, but some
Oxygen should be provided to all patients with severe asthma,         studies have shown that repeat doses of 250 mcg or 500 mcg
even those with normal oxygenation. As noted above, successful        every 20 minutes may be beneficial.17 A recent meta-analysis
treatment with 2-agonists may cause an initial decrease in            indicated a reduced number of hospital admissions associated
oxygen saturation because the resultant bronchodilation can           with treatment with ipratropium bromide, particularly in patients
initially increase the ventilation-perfusion mismatch.                with severe exacerbations.18

Inhaled 2-Agonists                                                    Magnesium Sulfate
Short-acting -agonists provide rapid, dose-dependent bron-            When combined with nebulized -adrenergic agents and corti-
chodilation with minimal side effects. Because the dose deliv-        costeroids, IV magnesium sulfate can moderately improve pul-
ered depends on the patient’s lung volume and inspiratory flow        monary function in patients with asthma.19 Magnesium causes
rate, the same dose can be used in most patients regardless of age    relaxation of bronchial smooth muscle independent of serum
or size. Studies have shown no difference in the effects of           magnesium level, with only minor side effects (flushing, light-
continuous versus intermittent administration of nebulized albu-      headedness). A Cochrane meta-analysis of 7 studies concluded
terol8,9; however, continuous administration was more effective       that IV magnesium sulfate improves pulmonary function and
in a subset of patients with severe exacerbations of asthma.8 A       reduces hospital admissions, particularly for patients with the
Cochrane meta-analysis showed no overall difference between           most severe exacerbations of asthma.20 The use of nebulized
the effects of albuterol delivered by metered-dose inhaler spacer     magnesium sulfate as an adjunct to nebulized -adrenergic
or nebulizer.10 If prior use of a metered-dose inhaler has not been   agents has been reported in a small case series to improve FEV1
effective, use of a nebulizer is reasonable.                          and SpO2,21 although a prior meta-analysis demonstrated only a
   Although albuterol is sometimes administered intravenously         trend toward improved pulmonary function with nebulized
(IV) in severe asthma, a systematic review of 15 clinical trials      magnesium.22 For those with severe refractory asthma, providers
found that IV 2-agonists, administered by either bolus or             may consider IV magnesium at the standard adult dose of 2 g
infusion, did not lead to significant improvements in any clinical    administered over 20 minutes.
outcome measure.9                                                     Epinephrine or Terbutaline
   Levalbuterol is the R-isomer of albuterol. Comparisons with        Epinephrine and terbutaline are adrenergic agents that can be
albuterol have produced mixed results, with some studies show-        given subcutaneously to patients with acute severe asthma. The
ing a slightly improved bronchodilator effect in the treatment of     dose of subcutaneous epinephrine (concentration 1:1000) is 0.01
acute asthma in the ED.11 There is no evidence that levalbuterol      mg/kg, divided into 3 doses of approximately 0.3 mg adminis-
should be favored over albuterol.                                     tered at 20-minute intervals. Although the nonselective adrener-
   One of the most common adjuncts used with -agonist                 gic properties of epinephrine may cause an increase in heart rate,
treatment, particularly in the first hours of treatment, include      myocardial irritability, and increased oxygen demand, its use is
anticholinergic agents (see “Adjunctive Therapies” below for          well-tolerated, even in patients 35 years of age.23 Terbutaline
more detail). When combined with short-acting -agonists,              is given in a subcutaneous dose of 0.25 mg, which can be
anticholinergic agents such as ipratropium can produce a              repeated every 20 minutes for 3 doses. There is no evidence that
clinically modest improvement in lung function compared               subcutaneous epinephrine or terbutaline has advantages over
with short-acting -agonists alone.12,13                               inhaled 2-agonists. Epinephrine has been administered IV
                                                                      (initiated at 0.25 mcg/min to 1 mcg/min continuous infusion) in
Corticosteroids
Systemic corticosteroids are the only treatment for the inflam-       severe asthma; however, 1 retrospective investigation indicated a
matory component of asthma proven to be effective for acute           4% incidence of serious side effects. There is no evidence of
asthma exacerbations. Because the antiinflammatory effects            improved outcomes with IV epinephrine compared with selec-
after administration may not be apparent for 6 to 12 hours,           tive inhaled 2-agonists.24
corticosteroids should be administered early. The early use of        Ketamine
systemic steroids hastens the resolution of airflow obstruction       Ketamine is a parenteral, dissociative anesthetic with bronchodi-
and may reduce admission to the hospital.14 Although there may        latory properties that also can stimulate copious bronchial
be no difference in clinical effects between oral and IV formu-       secretions. One case series25 suggested substantial efficacy,
lations of corticosteroids,15,16 the IV route is preferable in        whereas 2 published randomized trials in children26,27 found no
patients with severe asthma. In adults a typical initial dose of      benefit of ketamine when compared with standard care. Keta-
methylprednisolone is 125 mg (dose range: 40 mg to 250 mg);           mine has sedative and analgesic properties that may be useful if
a typical dose of dexamethasone is 10 mg.                             intubation is planned.

Adjunctive Therapies                                                  Heliox
Anticholinergics                                                      Heliox is a mixture of helium and oxygen (usually a 70:30
Ipratropium bromide is an anticholinergic bronchodilator phar-        helium to oxygen ratio mix) that is less viscous than ambient air.
macologically related to atropine. The nebulizer dose is 500          Heliox has been shown to improve the delivery and deposition
mcg.15,16 Ipratropium bromide has a slow onset of action              of nebulized albuterol28; however, a recent meta-analysis of
(approximately 20 minutes), with peak effectiveness at 60 to 90       clinical trials did not support its use as initial treatment for
                     Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
Vanden Hoek et al          Part 12: Cardiac Arrest in Special Situations                 S831


patients with acute asthma.29 Because the heliox mixture re-           provider should use the largest endotracheal tube available
quires at least 70% helium for effect, it cannot be used if the        (usually 8 or 9 mm) to decrease airway resistance. Immediately
patient requires 30% oxygen.                                           after intubation, endotracheal tube placement should be con-
                                                                       firmed by clinical examination and waveform capnography. A
Methylxanthines
Although once considered a mainstay in the treatment of acute          chest radiograph should then be performed.
asthma, methylxanthines are no longer recommended because of
their erratic pharmacokinetics, known side effects, and lack of        Troubleshooting After Intubation
evidence of benefit.30                                                 When severe bronchoconstriction is present, breath stacking
                                                                       (so-called auto-PEEP) can develop during positive-pressure
Leukotriene Antagonists                                                ventilation, leading to complications such as hyperinflation,
Leukotriene antagonists improve lung function and decrease the         tension pneumothorax, and hypotension. During manual or
need for short-acting 2-agonists for long-term asthma therapy,         mechanical ventilation, a slower respiratory rate should be used
but their effectiveness during acute exacerbations of asthma is        with smaller tidal volumes (eg, 6 to 8 mL/kg),36 shorter inspira-
unproven.
                                                                       tory time (eg, adult inspiratory flow rate 80 to 100 mL/min), and
Inhaled Anesthetics                                                    longer expiratory time (eg, inspiratory to expiratory ratio 1:4 or
Case reports in adults31 and children32 suggest a benefit of the       1:5) than generally would be provided to patients without
potent inhalation anesthetics sevoflurane and isoflurane for           asthma.37 Management of mechanical ventilation will vary
patients with life-threatening asthma unresponsive to maximal          based on patient-ventilation characteristics. Expert consultation
conventional therapy. These agents may have direct bronchodi-          should be obtained.
lator effects. In addition, the anesthetic effect of these drugs          Mild hypoventilation (permissive hypercapnia) reduces the
increases the ease of mechanical ventilation and reduces oxygen        risk of barotrauma. Hypercapnia is typically well tolerated.38,39
demand and carbon dioxide production. This therapy requires            Sedation is often required to optimize ventilation, decrease
expert consultation in an intensive care setting, and its effective-   ventilator dyssynchrony (and therefore auto-PEEP), and mini-
ness has not been evaluated in randomized clinical studies.            mize barotrauma after intubation. Because delivery of inhaled
                                                                       medications may be inadequate before intubation, the provider
Assisted Ventilation
                                                                       should continue to administer inhaled albuterol treatments
Noninvasive Positive-Pressure Ventilation                              through the endotracheal tube.
Noninvasive positive-pressure ventilation (NIPPV) may offer               Four common causes of acute deterioration in any intubated
short-term support for patients with acute respiratory failure and
                                                                       patient are recalled by the mnemonic DOPE (tube Displace-
may delay or eliminate the need for endotracheal intuba-
                                                                       ment, tube Obstruction, Pneumothorax, Equipment failure).
tion.33–35 This therapy requires that the patient is alert and has
                                                                       Auto-PEEP is another common cause of deterioration in patients
adequate spontaneous respiratory effort. Bilevel positive
                                                                       with asthma. If the asthmatic patient’s condition deteriorates or
airway pressure (BiPAP), the most common method of
delivering NIPPV, allows for separate control of inspiratory           if it is difficult to ventilate the patient, check the ventilator for
and expiratory pressures.                                              leaks or malfunction; verify endotracheal tube position; elimi-
                                                                       nate tube obstruction (eliminate any mucous plugs and kinks);
Endotracheal Intubation With Mechanical Ventilation                    evaluate for auto-PEEP; and rule out a pneumothorax.
Endotracheal intubation is indicated for patients who present             High-end expiratory pressure can be reduced quickly by
with apnea, coma, persistent or increasing hypercapnia, exhaus-        separating the patient from the ventilator circuit; this will allow
tion, severe distress, and depression of mental status. Clinical       PEEP to dissipate during passive exhalation. If auto-PEEP
judgment is necessary to assess the need for immediate endo-           results in significant hypotension, assisting with exhalation by
tracheal intubation for these critically ill patients. Endotracheal
                                                                       pressing on the chest wall after disconnection of the ventilator
intubation does not solve the problem of small airway constric-
                                                                       circuit will allow active exhalation and should lead to immediate
tion in patients with severe asthma; thus, therapy directed toward
                                                                       resolution of hypotension. To minimize auto-PEEP, decrease the
relief of bronchoconstriction should be continued. Mechanical
                                                                       respiratory rate or tidal volume or both. If auto-PEEP persists
ventilation in the asthmatic patient can be difficult and associ-
ated risks require careful management. Intubation and positive-        and the patient displays ventilator dyssynchrony despite ade-
pressure ventilation can trigger further bronchoconstriction and       quate sedation, paralytic agents may be considered.
complications such as breath stacking that result from incom-             In exceedingly rare circumstances, aggressive treatment for
plete expiration, air trapping, and buildup of positive end-           acute respiratory failure due to severe asthma will not provide
expiratory pressure (ie, intrinsic or auto-PEEP). This breath          adequate gas exchange. There are case reports that describe
stacking can cause barotrauma. Decreasing tidal volume may             successful use of extracorporeal membrane oxygenation
avoid auto-PEEP and high peak airway pressures. Optimal                (ECMO) in adult and pediatric patients40 – 43 with severe asthma
ventilator management requires expert consultation and ongoing         after other aggressive measures have failed to reverse hyoxemia
careful review of ventilation flow and pressure curves. Although       and hypercarbia.
endotracheal intubation introduces risks, it should be performed
when necessary based on clinical condition.                            BLS Modifications
   Rapid sequence intubation is the technique of choice and            BLS treatment of cardiac arrest in asthmatic patients is
should be performed by an expert in airway management. The             unchanged.
                     Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
S832       Circulation        November 2, 2010


ACLS Modifications                                                    to cardiac arrest.61,62 Myocardial ischemia and acute myocardial
When cardiac arrest occurs in the patient with acute asthma,          infarction, malignant arrhythmias, and cardiovascular depression
standard ACLS guidelines should be followed.                          can also contribute to rapid hemodynamic deterioration and
   Case series and case reports describe a novel technique of         cardiac arrest.63 Additionally, cardiac dysfunction may result
cardiopulmonary resuscitation (CPR) termed “lateral chest com-        from underlying disease or development of myocardial ischemia
pressions”; however, there is insufficient evidence to recom-         due to hypotension or following administration of
mend this technique over standard techniques.44 –50                   epinephrine.64,65
   The adverse effect of auto-PEEP on coronary perfusion                 There are no randomized controlled trials evaluating alterna-
pressure and capacity for successful defibrillation has been          tive treatment algorithms for cardiac arrest due to anaphylaxis.
described in patients in cardiac arrest without asthma.51,52 More-    Evidence is limited to case reports and extrapolations from
over, the adverse effect of auto-PEEP on hemodynamics in              nonfatal cases, interpretation of pathophysiology, and consensus
asthmatic patients who are not in cardiac arrest has also been        opinion. Providers must be aware that urgent support of airway,
well-described.53–56 Therefore, since the effects of auto-PEEP in     breathing, and circulation is essential in suspected anaphylactic
an asthmatic patient with cardiac arrest are likely quite severe, a   reactions.
ventilation strategy of low respiratory rate and tidal volume is         Because of limited evidence, the management of cardiac
reasonable (Class IIa, LOE C). During arrest a brief disconnec-       arrest secondary to anaphylaxis should be treated with standard
tion from the bag mask or ventilator may be considered, and           BLS and ACLS. The following therapies are largely consensus-
compression of the chest wall to relieve air-trapping can be          based but commonly used and widely accepted in the manage-
effective (Class IIa, LOE C).                                         ment of the patient with anaphylaxis who is not in cardiac arrest.
   For all asthmatic patients with cardiac arrest, and especially
for patients in whom ventilation is difficult, the possible diag-     BLS Modifications
nosis of a tension pneumothorax should be considered and
                                                                      Airway
treated (Class I, LOE C).                                             Early and rapid advanced airway management is critical and
                                                                      should not be unnecessarily delayed. Given the potential for the
       Part 12.2: Cardiac Arrest Associated                           rapid development of oropharyngeal or laryngeal edema,66
                With Anaphylaxis                                      immediate referral to a health professional with expertise in
Anaphylaxis is an allergic reaction characterized by multisystem      advanced airway placement is recommended (Class I, LOE C).
involvement, including skin, airway, vascular system, and gas-
trointestinal tract. Severe cases may result in complete obstruc-     Circulation
tion of the airway and cardiovascular collapse from vasogenic         The intramuscular (IM) administration of epinephrine (epineph-
shock. Anaphylaxis accounts for about 500 to 1000 deaths per          rine autoinjectors, eg, the EpiPen™) in the anterolateral aspect
year in the United States.57                                          of the middle third of the thigh provides the highest peak blood
   The term classic anaphylaxis refers to hypersensitivity reac-      levels.67 Absorption and subsequent achievement of maximum
tions mediated by the immunoglobulins IgE and IgG. Prior              plasma concentration after subcutaneous administration is
sensitization to an allergen produces antigen-specific immuno-        slower than the IM route and may be significantly delayed with
globulins. Subsequent reexposure to the allergen provokes the         shock.67
anaphylactic reaction, although many anaphylactic reactions              Epinephrine68 should be administered early by IM injection to
occur with no documented prior exposure. Pharmacological              all patients with signs of a systemic allergic reaction, especially
agents, latex, foods, and stinging insects are among the most         hypotension, airway swelling, or difficulty breathing (Class I,
common causes of anaphylaxis described.                               LOE C). The recommended dose is 0.2 to 0.5 mg (1:1000) IM
                                                                      to be repeated every 5 to 15 minutes in the absence of clinical
Signs and Symptoms                                                    improvement (Class I, LOE C).69 The adult epinephrine IM
The initial symptoms of anaphylaxis are often nonspecific             auto-injector will deliver 0.3 mg of epinephrine and the pediatric
and include tachycardia, faintness, cutaneous flushing, urti-         epinephrine IM auto-injector will deliver 0.15 mg of epineph-
caria, diffuse or localized pruritus, and a sensation of impend-      rine. In both anaphylaxis and cardiac arrest the immediate use of
ing doom. Urticaria is the most common physical finding.              an epinephrine autoinjector is recommended if available (Class I,
The patient may be agitated or anxious and may appear either          LOE C).
flushed or pale.
   A common early sign of respiratory involvement is rhinitis.        ACLS Modifications
As respiratory compromise becomes more severe, serious upper
                                                                      Airway
airway (laryngeal) edema may cause stridor and lower airway           Early recognition of the potential for a difficult airway in
edema (asthma) may cause wheezing. Upper airway edema can             anaphylaxis is paramount in patients who develop hoarseness,
also be a sign in angiotensin converting enzyme inhibitor-
                                                                      lingual edema, stridor, or oropharyngeal swelling. Planning for
induced angioedema or C1 esterase inhibitor deficiency with
                                                                      advanced airway management, including a surgical airway,70 is
spontaneous laryngeal edema.58 – 60
                                                                      recommended (Class I, LOE C).
   Cardiovascular collapse is common in severe anaphylaxis. If
not promptly corrected, vasodilation and increased capillary          Fluid Resuscitation
permeability, causing decreased preload and relative hypovole-        In a prospective evaluation of volume resuscitation after diag-
mia of up to 37% of circulating blood volume, can rapidly lead        nostic sting challenge, repeated administration of 1000-mL
                     Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
Vanden Hoek et al         Part 12: Cardiac Arrest in Special Situations                 S833


bolus doses of isotonic crystalloid (eg, normal saline) titrated to   these advanced techniques may be considered in clinical situa-
systolic blood pressure above 90 mm Hg was used successfully          tions where the required professional skills and equipment are
in patients whose hypotension did not respond immediately to          immediately available (Class IIb, LOE C).
vasoactive drugs.61,71 Vasogenic shock from anaphylaxis may
require aggressive fluid resuscitation (Class IIa, LOE C).                    Part 12.3: Cardiac Arrest Associated
                                                                                         With Pregnancy
Vasopressors
There are no human trials establishing the role of epinephrine or     Scope of the Problem
preferred route of administration in anaphylactic shock managed       The Confidential Enquiries into Maternal and Child Health
by ACLS providers.68 In an animal study of profound anaphy-           (CEMACH) data set constitutes the largest population-based
lactic shock, IV epinephrine restored blood pressure to baseline;     data set on this target population.92 The overall maternal mor-
however, the effect was limited to the first 15 minutes after         tality rate was calculated at 13.95 deaths per 100 000 materni-
shock, and no therapeutic effect was observed with the same           ties. There were 8 cardiac arrests with a frequency calculated at
dose of epinephrine administered IM or subcutaneously.72              0.05 per 1000 maternities, or 1:20 000. The frequency of cardiac
Therefore, when an IV line is in place, it is reasonable to           arrest in pregnancy is on the rise with previous reports estimating
consider the IV route as an alternative to IM administration of       the frequency to be 1:30 000 maternities.93 Despite pregnant
epinephrine in anaphylactic shock (Class IIa, LOE C).                 women being younger than the traditional cardiac arrest patient,
   For patients not in cardiac arrest, IV epinephrine 0.05 to 0.1     the survival rates are poorer, with one case series reporting a
mg (5% to 10% of the epinephrine dose used routinely in cardiac       survival rate of 6.9%.93,94
arrest) has been used successfully in patients with anaphylactic         During attempted resuscitation of a pregnant woman, provid-
shock.73 Because fatal overdose of epinephrine has been repo-         ers have 2 potential patients: the mother and the fetus. The best
rted,64,71,74,75 close hemodynamic monitoring is recommended          hope of fetal survival is maternal survival. For the critically ill
(Class I, LOE B).                                                     pregnant patient, rescuers must provide appropriate resuscitation
   In a study of animals sensitized by ragweed, a continuous IV       based on consideration of the physiological changes caused by
infusion of epinephrine maintained a mean arterial pressure at        pregnancy.
70% of preshock levels better than no treatment or bolus
epinephrine treatment (IV, subcutaneous, or IM).76 Furthermore,       Key Interventions to Prevent Arrest
                                                                      The following interventions are the standard of care for
a recent human study suggests that careful titration of a contin-
                                                                      treating the critically ill pregnant patient (Class I, LOE C):
uous infusion of IV epinephrine (5 to 15 mcg/min), based on
severity of reaction and in addition to crystalloid infusion, may     ●   Place the patient in the full left-lateral position to relieve
be considered in treatment of anaphylactic shock.71 Therefore,            possible compression of the inferior vena cava. Uterine
IV infusion of epinephrine is a reasonable alternative to IV              obstruction of venous return can produce hypotension and
boluses for treatment of anaphylaxis in patients not in cardiac           may precipitate arrest in the critically ill patient.95,96
arrest (Class IIa, LOE C) and may be considered in postarrest         ●   Give 100% oxygen.
management (Class IIb, LOE C).                                        ●   Establish intravenous (IV) access above the diaphragm.
   Recently vasopressin has been used successfully in patients        ●   Assess for hypotension; maternal hypotension that war-
with anaphylaxis (with or without cardiac arrest) who did not             rants therapy has been defined as a systolic blood pressure
respond to standard therapy.77–79 Other small case series de-               100 mm Hg or 80% of baseline.97,98 Maternal hypo-
scribed successful results with administration of alternative             tension can result in reduced placental perfusion.99 –102 In
  -agonists such as norepinephrine,80 methoxamine,81,82 and               the patient who is not in arrest, both crystalloid and colloid
metaraminol.83– 85 Alternative vasoactive drugs (vasopressin,             solutions have been shown to increase preload.103
norepinephrine, methoxamine, and metaraminol) may be                  ●   Consider reversible causes of critical illness and treat
considered in cardiac arrest secondary to anaphylaxis that                conditions that may contribute to clinical deterioration as
does not respond to epinephrine (Class IIb, LOE C). No                    early as possible.
randomized controlled trials have evaluated epinephrine ver-
sus the use of alternative vasoactive drugs for cardiac arrest        Resuscitation of the Pregnant Patient in Cardiac
due to anaphylaxis.                                                   Arrest (Figure 1)
                                                                      There are no randomized controlled trials evaluating the effect of
Other Interventions                                                   specialized obstetric resuscitation versus standard care in preg-
There are no prospective randomized clinical studies evaluating
                                                                      nant patients in cardiac arrest. There are reports in the literature
the use of other therapeutic agents in anaphylactic shock or
                                                                      of patients not in arrest that describe the science behind impor-
cardiac arrest. Adjuvant use of antihistamines (H1 and H2
                                                                      tant physiological changes that occur in pregnancy that may
antagonist),86,87 inhaled -adrenergic agents,88 and IV cortico-
                                                                      influence treatment recommendations and guidelines for resus-
steroids89 has been successful in management of the patient with
                                                                      citation from cardiac arrest in pregnancy.
anaphylaxis and may be considered in cardiac arrest due to
anaphylaxis (Class IIb, LOE C).                                       BLS Modifications
Extracorporeal Support of Circulation                                 Patient Positioning
Cardiopulmonary bypass has been successful in isolated case           Patient position has emerged as an important strategy to improve
reports of anaphylaxis followed by cardiac arrest.90,91 Use of        the quality of CPR and resultant compression force and output.
                     Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
S834        Circulation          November 2, 2010




                                                                                                              Figure 1. Maternal cardiac
                                                                                                              arrest algorithm.




The pregnant uterus can compress the inferior vena cava,                      Two studies in pregnant women not in arrest found that
impeding venous return and thereby reducing stroke volume and              manual left uterine displacement, which is done with the patient
cardiac output. Reports of noncardiac arrest parturients indicate          supine, is as good as or better than left-lateral tilt in relieving
that left-lateral tilt results in improved maternal hemodynamics           aortocaval compression (as assessed by the incidence of hypo-
of blood pressure, cardiac output, and stroke volume96,98,104; and         tension and use of ephedrine).111,112
improved fetal parameters of oxygenation, nonstress test, and                 Therefore, to relieve aortocaval compression during chest
fetal heart rate.100 –102                                                  compressions and optimize the quality of CPR, it is reasonable
   Although chest compressions in the left-lateral tilt position are       to perform manual left uterine displacement in the supine
feasible in a manikin study,105 they result in less forceful chest         position first (Class IIa, LOE C). Left uterine displacement can
compressions than are possible in the supine position.106 Two              be performed from either the patient’s left side with the
studies found no improvement in maternal hemodynamic or fetal              2-handed technique (Figure 2) or the patient’s right side with the
parameters with 10° to 20° left-lateral tilt in patients not in            1-handed technique (Figure 3), depending on the positioning of
arrest.107,108 One study reported more aortic compression at 15°           the resuscitation team. If this technique is unsuccessful, and an
left-lateral tilt compared with a full left-lateral tilt.97 In addition,   appropriate wedge is readily available, then providers may
aortic compression has been found at 30° of tilt,109 however               consider placing the patient in a left-lateral tilt of 27° to 30°,106
the majority of these patients were in labor.                              using a firm wedge to support the pelvis and thorax (Figure 4)
   If left-lateral tilt is used to improve maternal hemodynamics           (Class IIb, LOE C).
during cardiac arrest, the degree of tilt should be maximized.                If chest compressions remain inadequate after lateral uterine
However, at a tilt 30° the patient may slide or roll off the               displacement or left-lateral tilt, immediate emergency cesarean
                                                                           section should be considered. (See “Emergency Cesarean Sec-
inclined plane,106 so this degree of tilt may not be practical
                                                                           tion in Cardiac Arrest,” below.)
during resuscitation. Although important, the degree of tilt is
difficult to estimate reliably; 1 study reported that the degree of        Airway
table tilt is often overestimated.110 Using a fixed, hard wedge of         Airway management is more difficult during pregnancy
a predetermined angle may help.                                            (see “ACLS Modifications: Airway,” below), and placing the
                      Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
Vanden Hoek et al         Part 12: Cardiac Arrest in Special Situations                 S835




Figure 2. . Left uterine displacement with 2-handed technique.
                                                                      Figure 4. Patient in a 30° left-lateral tilt using a firm wedge to
patient in a tilt may increase the difficulty. In addition, altered   support pelvis and thorax.
airway anatomy increases the risks of aspiration and rapid
desaturation. Therefore, optimal use of bag-mask ventilation          of the diaphragm and abdominal contents caused by the gravid
and suctioning, while preparing for advanced airway place-            uterus.
ment (see “ACLS Modifications”) is critical.
                                                                      Defibrillation
Breathing                                                             Use of an AED on a pregnant victim has not been studied but is
Pregnant patients can develop hypoxemia rapidly because of            reasonable.
decreased functional residual capacity and increased oxygen
demand. One study in normal pregnancy reported increased              ACLS Modifications
intrapulmonary shunting of 12.8% to 15.3% compared with the           There should be no delay in delivering usual treatments during
nonpregnant state, in which the normal value is 2% to 5%,113          the management of cardiac arrest in pregnancy.
which further increases the risk of hypoxemia. Ventilation
volumes may need to be reduced because the mother’s dia-              Airway
phragm is elevated. Providers should be prepared to support           Pregnancy results in changes in airway mucosa, including
oxygenation and ventilation and monitor oxygen saturation             edema, friability, hypersecretion, and hyperemia.114,115 In addi-
closely.                                                              tion, 1 study found that the upper airway in the third trimester of
                                                                      pregnancy is smaller compared with that of nonpregnant women
Circulation                                                           and women in the postpartum period.116 Therefore, airway
Chest compressions should be performed slightly higher on the
                                                                      management of the pregnant patient may be more difficult than
sternum than normally recommended to adjust for the elevation
                                                                      airway management of the nonpregnant patient.
                                                                         There is significant literature recognizing the issue of failed
                                                                      intubation in obstetric anesthesia as a major cause of maternal
                                                                      morbidity and mortality.117,118 All providers involved in a
                                                                      resuscitation attempt should be aware of the increased risk for
                                                                      pregnancy-related complications in airway management. Intuba-
                                                                      tion with an endotracheal tube or supraglottic airway should be
                                                                      performed only by experienced providers if possible.
                                                                         Cheun et al119 found that during apnea desaturation in
                                                                      pregnant patients is significantly faster than in nonpreg-
                                                                      nant patients. Bag-mask ventilation with 100% oxygen
                                                                      before intubation is especially important in pregnancy
                                                                      (Class IIa, LOE B).120

                                                                      Circulation
                                                                      Changes in Pharmacokinetics
                                                                      One clinical pharmacokinetic study discovered an increase in the
                                                                      rate of glomerular filtration and volume of plasma during normal
 Figure 3. Left uterine displacement using 1-handed technique.        pregnancy.121 There is no evidence, however, that current
                     Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
S836       Circulation         November 2, 2010


medications or doses should be altered during management of             fibrinolytics are relatively contraindicated in pregnancy, PCI is
cardiac arrest in pregnancy; therefore, current recommended             the reperfusion strategy of choice for ST-elevation myocardial
drug dosages for use in resuscitation of adults should also be          infarction.
used in resuscitation of the pregnant patient.                             The number of babies born with congenital heart disease who
                                                                        now survive to adulthood has increased exponentially over the
Defibrillation                                                          last 3 decades.139,140 It is estimated that 85% of neonates born
Defibrillation should be performed at the recommended
                                                                        with congenital heart disease will survive to adulthood. There-
ACLS defibrillation doses (Class I, LOE C).122
                                                                        fore, more women with congenital heart disease are surviving to
   Although there are no studies documenting maternal or fetal
                                                                        have children, which translates into higher risk for a cardiac
complications with defibrillation, there are case reports123–130
                                                                        event during pregnancy. In fact, illnesses related to congenital
and case series131–133 that describe potential harm to the fetus
                                                                        heart disease and pulmonary hypertension are the third most
when an accidental electric shock (lightning, electric circuit) is
                                                                        common cause of maternal cardiac deaths.92
delivered directly to the mother. After a pregnant woman
receives an electric shock, the range of clinical presentations         Magnesium Sulfate Toxicity
varies from the mother feeling only a strange sensation with no         Patients with magnesium toxicity present with cardiac effects
fetal effects to fetal death either immediately or a few days after     ranging from ECG interval changes (prolonged PR, QRS and
the shock. Risk factors for adverse fetal outcomes include the          QT intervals) at magnesium levels of 2.5–5 mmol/L to AV nodal
magnitude of current and duration of contact. The greatest              conduction block, bradycardia, hypotension and cardiac arrest at
predictor of risk for adverse fetal outcome is if the current travels   levels of 6 –10 mmol/L. Neurological effects ranging from loss
through the uterus, because amniotic fluid most likely transmits        of tendon reflexes, sedation, severe muscular weakness, and
current in a manner similar to that transmitted via other body          respiratory depression are seen at levels of 4 –5 mmol/L. Other
fluids, which could increase the risk of fetal death or burns.          signs of magnesium toxicity include gastrointestinal symptoms
   Although there is a small risk of inducing fetal arrhythmias,        (nausea and vomiting), skin changes (flushing), and electrolyte/
cardioversion and defibrillation on the external chest are consid-      fluid abnormalities (hypophosphatemia, hyperosmolar dehydra-
ered safe at all stages of pregnancy.134 –136                           tion). Patients with renal failure and metabolic derangements can
   Some experts have raised concern that electric arcing may            develop toxicity after relatively lower magnesium doses.
occur if fetal monitors are attached during defibrillation of a            Iatrogenic overdose is possible in the pregnant woman who
pregnant woman, but there is no evidence to support this.               receives magnesium sulfate, particularly if the woman becomes
Overall it is reasonable to assume that if the shock is delivered       oliguric. Empirical calcium administration may be lifesaving in
to the mother’s thorax, there is very low to no risk of electric        these cases.141–143
arcing to fetal monitors. If internal or external fetal monitors are
attached during cardiac arrest in a pregnant woman, it is               Preeclampsia/Eclampsia
reasonable to remove them (Class IIb, LOE C).                           Preeclampsia/eclampsia develops after the 20th week of gesta-
                                                                        tion and can produce severe hypertension and ultimately diffuse
Treatment of Reversible Causes                                          organ-system failure. If untreated, maternal and fetal morbidity
The same reversible causes of cardiac arrest that occur in              and mortality may result.
nonpregnant women can occur during pregnancy. Providers
                                                                        Life-Threatening Pulmonary Embolism (PE)
should be familiar with pregnancy-specific diseases and proce-          Successful use of fibrinolytics in pregnant women has been
dural complications and during resuscitation attempts should try        reported for massive, life-threatening PE144 –146 and ische-
to identify common and reversible causes of cardiac arrest in           mic stroke.147 Pregnant women in cardiac arrest with
pregnancy.92                                                            suspected PE should be treated in accordance with the
Cardiac Disease                                                         ACLS guidelines (see Part 12.5: “Cardiac Arrest Associ-
Cardiac disease is the primary cause of maternal mortality,             ated With Pulmonary Embolism”).
according to the 2003 to 2005 Confidential Enquiries into
                                                                        Amniotic Fluid Embolism
Maternal and Child Health report.92 For example, the number of          Clinicians have reported successful use of cardiopulmonary
deaths from cardiac disease was 2.27 per 100,000 pregnancies,           bypass for pregnant women with a life-threatening amniotic
whereas the number of deaths from thrombosis and thrombo-
                                                                        fluid embolism during labor and delivery.148 The use of peri-
embolism was 1.94 per 100,000 pregnancies.92 The number of
                                                                        mortem cesarean section has resulted in maternal and neonatal
cardiac deaths during pregnancy has increased steadily since
                                                                        survival.149
1991. The most common causes of maternal death from cardiac
disease are myocardial infarction, followed by aortic dissec-           Anesthetic Complications
tion.92 A study completed in California also found that the             Anesthesia-related maternal morbidity and mortality continue to
incidence of myocardial infarction in pregnancy increased               be a major concern, which has led to development of specialized
throughout the 1990s.137 In addition, a nationwide review of            obstetric anesthesia techniques.118 Cardiac arrest may result
myocardial infarction in pregnancy in the United States found           from spinal shock as a result of regional anesthesia. Induction of
that the risk of myocardial infarction in pregnancy is 3 to 4 times     general anesthesia may lead to loss of airway control or
that of nonpregnant women of reproductive age.138                       pulmonary aspiration, and emergence from anesthesia can be
   Women are deferring pregnancy to older ages, increasing the          associated with hypoventilation or airway obstruction, leading to
chance that they will have atherosclerotic heart disease. Because       cardiac arrest.150 –155
                     Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
Vanden Hoek et al          Part 12: Cardiac Arrest in Special Situations               S837


Maternal Cardiac Arrest Not Immediately                                 described in 1986 and has been perpetuated in specialty guide-
Reversed by BLS and ACLS                                                lines.143,166 The rescue team is not required to wait 5 minutes
Emergency Cesarean Section in Cardiac Arrest                            before initiating emergency hysterotomy, and there are cir-
Resuscitation team leaders should activate the protocol for an          cumstances that support an earlier start.157 For instance, in an
emergency cesarean delivery as soon as cardiac arrest is identi-        obvious nonsurvivable injury,166,167–169 when the maternal
fied in a pregnant woman with an obviously gravid uterus. By            prognosis is grave and resuscitative efforts appear futile,
the time the physician is ready to deliver the baby, standard           moving straight to an emergency cesarean section may be
ACLS should be underway and immediately reversible causes of            appropriate, especially if the fetus is viable.
cardiac arrest should be ruled out. When the gravid uterus is              Many reports document long intervals between an urgent
large enough to cause maternal hemodynamic changes due to               decision for hysterotomy and actual delivery of the infant, far
aortocaval compression, emergency cesarean section should be            exceeding the obstetric guideline of 30 minutes for patients not
considered, regardless of fetal viability.                              in arrest.170,171 Very few cases of perimortem cesarean section
                                                                        fall within the recommended 5-minute period.94,166 Survival of
What Defines a Gravid Uterus With the Potential to                      the mother has been reported with perimortem cesarean section
Cause Aortocaval Compression?                                           performed up to 15 minutes after the onset of maternal cardiac
A study found that maternal aortocaval compression can occur            arrest.94,172–174 If emergency cesarean section cannot be per-
for singleton pregnancies at 20 weeks of gestational age.156            formed by the 5-minute mark, it may be advisable to prepare to
However, the exact gestational age at which aortocaval com-             evacuate the uterus while the resuscitation continues. (Class IIb,
pression occurs is not consistent, especially with multiple-            LOE C).
gestation pregnancies or intrauterine growth retardation, and              At 24 to 25 weeks of gestation, the best survival rate for the
gestational age and number of fetuses may not always be known           infant occurs when the infant is delivered no more than 5
in the emergency situation. Fundal height is often used to              minutes after the mother’s heart stops beating.175–178 Typically
estimate gestational age. In a singleton gestation, by 20 weeks         this requires that the provider begin the hysterotomy about 4
fundal height is approximately at the level of the umbilicus157;        minutes after cardiac arrest. At gestational ages 30 weeks,
however the fundus may reach the umbilicus between 15 and 19            infant survival has been seen even when delivery occurred after
weeks of gestation.158 Fundal height may also be skewed by              5 minutes from onset of maternal cardiac arrest.166 In a recent
other factors such as abdominal distention157 and increased body        retrospective cohort series, neonatal survival was documented
mass index; therefore fundal height may be a poor predictor of          when delivery occurred within 30 minutes after onset of mater-
gestational age.                                                        nal cardiac arrest.94
   One review of emergency cesarean sections in maternal                   When there is an obvious gravid uterus, the emergency
cardiac arrest before the third trimester concluded that if the         cesarean section team should be activated at the onset of
fundus extends above the level of the umbilicus, aortocaval             maternal cardiac arrest (Class I, LOE B). Emergency cesarean
compression can occur, and emergency cesarean section should            section may be considered at 4 minutes after onset of maternal
be performed regardless of gestational age.158                          cardiac arrest if there is no return of spontaneous circulation
   Two cases of maternal cardiac arrest in early pregnancy of 13        (Class IIb, LOE C).
to 15 weeks were reported in which the mother was resuscitated
without an emergency cesarean section being performed and the           Institutional Preparation for Maternal
pregnancy continued to successful delivery of a live infant at          Cardiac Arrest
term.159,160 Not every pregnant woman in cardiac arrest is a            Experts and organizations have emphasized the importance
candidate for an emergency cesarean section; the decision               of preparation.143,179 Providers at medical centers must
depends on whether or not the gravid uterus is thought to               review whether performance of an emergency hysterotomy
interfere with maternal hemodynamics.                                   is feasible, and if so, they must identify the best means of
                                                                        accomplishing this procedure rapidly. Team planning
Why Perform an Emergency Cesarean Section in                            should be done in collaboration with the obstetric, neona-
Cardiac Arrest?
Several case reports of emergency cesarean section in maternal          tal, emergency, anesthesiology, intensive care, and cardiac
cardiac arrest indicate a return of spontaneous circulation or          arrest services (Class I, LOE C).
improvement in maternal hemodynamic status only after the
                                                                        Post–Cardiac Arrest Care
uterus has been emptied.94 –96,143,149,161–166 In a case series of 38
                                                                        One case report showed that post– cardiac arrest hypothermia
cases of perimortem cesarean section, 12 of 20 women for
                                                                        can be used safely and effectively in early pregnancy without
whom maternal outcome was recorded had return of spontane-
                                                                        emergency cesarean section (with fetal heart monitoring), with
ous circulation immediately after delivery. No cases of worsened
                                                                        favorable maternal and fetal outcome after a term delivery.159 No
maternal status after cesarean section were reported.166 The
                                                                        cases in the literature have reported the use of therapeutic
critical point to remember is that both mother and infant may die
                                                                        hypothermia with perimortem cesarean section. Therapeutic
if the provider cannot restore blood flow to the mother’s heart.94
                                                                        hypothermia may be considered on an individual basis after
The Importance of Timing With Emergency                                 cardiac arrest in a comatose pregnant patient based on current
Cesarean Section                                                        recommendations for the nonpregnant patient (Class IIb, LOE
The 5-minute window that providers have to determine if                 C). During therapeutic hypothermia of the pregnant patient, it is
cardiac arrest can be reversed by BLS and ACLS was first                recommended that the fetus be continuously monitored for
                     Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
S838       Circulation        November 2, 2010


bradycardia as a potential complication, and obstetric and            effective in patients with cardiovascular instability as outlined
neonatal consultation should be sought (Class I, LOE C).              below. Current BLS and ACLS should be used to manage
                                                                      cardiac arrest associated with all electrolyte disturbances.
          Part 12.4: Cardiac Arrest in the
                  Morbidly Obese                                      Potassium (K )
Morbid obesity can provide challenges during the resuscitation        Potassium is maintained mainly in the intracellular compartment
attempt. Airway management may be more challenging, and               through the action of the Na /K ATPase pump. The magni-
changes to the thorax may make resuscitative efforts more             tude of the potassium gradient across cell membranes deter-
demanding. Evidence from 2 case studies,180,181 1 case series,182     mines excitability of nerve and muscle cells, including the
and 1 related clinical study183 indicated no differences in           myocardium.
survival based on patient weight. However, one large case series         Potassium is tightly regulated. Under normal conditions po-
demonstrated lower survival for morbidly obese children who           tential differences across membranes, especially cardiac, are not
required in-hospital pediatric CPR.184                                affected by alterations in potassium level. Rapid or significant
                                                                      changes in serum concentrations of potassium result from the
BLS and ACLS Modifications
                                                                      shifting of potassium from one space to another and may have
No modifications to standard BLS or ACLS care have been
                                                                      life-threatening consequences.
proven efficacious, although techniques may need to be adjusted
due to the physical attributes of individual patients.
                                                                      Hyperkalemia
                                                                      Hyperkalemia is one of the few potentially lethal electrolyte
  Part 12.5: Cardiac Arrest Associated With
                                                                      disturbances. Severe hyperkalemia (defined as a serum potas-
             Pulmonary Embolism
Pulmonary embolism (PE) can result in cardiovascular collapse         sium concentration 6.5 mmol/L) occurs most commonly from
and cardiac arrest. Although cardiac arrest caused by PE often        renal failure or from release of potassium from cells and can
presents as pulseless electric activity (PEA), not all cases of PEA   cause cardiac arrhythmias and cardiac arrest. In 1 retrospective
are caused by PE.                                                     in-hospital study of 29 063 patients, hyperkalemia was found to
                                                                      be directly responsible for sudden cardiac arrest in 7 cases.199
ACLS Modifications                                                    Acute kidney injury was present in all the arrest cases, accom-
In patients with cardiac arrest and without known PE, routine         panied by acute pancreatitis in 3 cases and acute hepatic failure
fibrinolytic treatment given during CPR shows no benefit185,186       in 2 cases. Overall renal failure and drug treatment were the most
and is not recommended (Class III, LOE A).                            common causes of hyperkalemia, with the most severe cases
   In patients with cardiac arrest and presumed PE, however, the      occurring when excessive IV potassium was administered to a
use of fibrinolytics during CPR may improve the patient’s             patient with renal insufficiency.
chance of survival.187–194 Despite the potential to increase the         Although severe hyperkalemia may cause flaccid paralysis,
risk of severe bleeding, fibrinolytics may improve survival to        paresthesia, depressed deep tendon reflexes, or respiratory dif-
discharge and long-term neurological function in patients with        ficulties,200 –202 the first indicator of hyperkalemia may be the
presumed PE-induced cardiac arrest.193–196 Emergency echocar-         presence of peaked T waves (tenting) on the electrocardiogram
diography may be helpful in determining the presence of               (ECG). As serum potassium rises, the ECG may progressively
thrombus or PE.                                                       develop flattened or absent P waves, a prolonged PR interval,
   In a small number of patients, percutaneous mechanical             widened QRS complex, deepened S waves, and merging of S
thromboembolectomy during CPR has been performed success-             and T waves (Figure 5). If hyperkalemia is left untreated, a
fully.189 Surgical embolectomy has also been used successfully
                                                                      sine-wave pattern, idioventricular rhythms, and asystolic cardiac
in some patients with PE-induced cardiac arrest.191,197,198
                                                                      arrest may develop.203,204
   In patients with cardiac arrest due to presumed or known PE,
it is reasonable to administer fibrinolytics (Class IIa, LOE B).      ACLS Modifications in Management of Severe
Survival has been described with percutaneous mechanical              Cardiotoxicity or Cardiac Arrest Due to Hyperkalemia
thrombectomy or surgical embolectomy with or without prior            Treatment of severe hyperkalemia aims at protecting the heart
treatment with fibrinolysis.                                          from the effects of hyperkalemia by antagonizing the effect of
                                                                      potassium on excitable cell membranes, forcing potassium into
  Part 12.6: Cardiac Arrest Associated With                           cells to remove it promptly from the circulation, and removing
  Life-Threatening Electrolyte Disturbances                           potassium from the body. Therapies that shift potassium will act
Electrolyte abnormalities can be associated with cardiovascular       rapidly but are temporary and thus may need to be repeated. In
emergencies and may cause or contribute to cardiac arrest,            order of urgency, treatment includes the following:
hinder resuscitative efforts, and affect hemodynamic recovery
after cardiac arrest. An evidence-based review in 2010 focused           Stabilize myocardial cell membrane:
on electrolyte abnormalities most often associated with cardiac            Calcium chloride (10%): 5 to 10 mL (500 to 1000 mg)
arrest.                                                                    IV over 2 to 5 minutes or calcium gluconate (10%): 15
   Early consideration may be given to using selective methods             to 30 mL IV over 2 to 5 minutes
of therapeutic management in addition to standard ACLS pro-              Shift potassium into cells:
tocols that can be provided rapidly and have been shown to be              Sodium bicarbonate: 50 mEq IV over 5 minutes
                     Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
Vanden Hoek et al          Part 12: Cardiac Arrest in Special Situations               S839


                                                                       pointes, is largely based on historical case reports that report
                                                                       slow infusion of potassium over hours.212 The effect of bolus
                                                                       administration of potassium for cardiac arrest suspected to be
                                                                       secondary to hypokalemia is unknown and ill advised (Class III,
                                                                       LOE C).

                                                                       Sodium (Na )
                                                                       Sodium is the major intravascular ion that influences serum
                                                                       osmolality. Sodium abnormalities are unlikely to lead to cardiac
                                                                       arrest, and there are no specific recommendations for either
                                                                       checking or treating sodium during cardiac arrest. Disturbances
                                                                       in sodium level are unlikely to be the primary cause of severe
                                                                       cardiovascular instability.

                                                                       Magnesium (Mg           )
                                                                       Magnesium is an essential electrolyte and an important cofactor
                                                                       for multiple enzymes, including ATPase. Magnesium is neces-
                                                                       sary for the movement of sodium, potassium, and calcium into
                                                                       and out of cells and plays an important role in stabilizing
                                                                       excitable membranes. The presence of a low plasma magnesium
                                                                       concentration has been associated with poor prognosis in cardiac
                                                                       arrest patients.208,213–216

                                                                       Hypermagnesemia
                                                                       Hypermagnesemia is defined as a serum magnesium concentra-
                                                                       tion 2.2 mEq/L (normal: 1.3 to 2.2 mEq/L). Neurological
                                                                       symptoms of hypermagnesemia include muscular weakness,
                                                                       paralysis, ataxia, drowsiness, and confusion. Hypermagnesemia
            Figure 5. ECG changes in hyperkalemia.
                                                                       can produce vasodilation and hypotension.217 Extremely high
                                                                       serum magnesium levels may produce a depressed level of
    Glucose plus insulin: mix 25 g (50 mL of D50) glucose
                                                                       consciousness, bradycardia, cardiac arrhythmias, hypoventila-
    and 10 U regular insulin and give IV over 15 to 30
                                                                       tion, and cardiorespiratory arrest.208,215,216
    minutes
    Nebulized albuterol: 10 to 20 mg nebulized over 15                 ACLS Modifications in Management of Cardiac Arrest
    minutes                                                            and Severe Cardiotoxicity Due to Hypermagnesemia
   Promote potassium excretion:                                        Administration of calcium (calcium chloride [10%] 5 to 10 mL
    Diuresis: furosemide 40 to 80 mg IV                                or calcium gluconate [10%] 15 to 30 mL IV over 2 to 5 minutes)
    Kayexalate: 15 to 50 g plus sorbitol per oral or per               may be considered during cardiac arrest associated with hyper-
    rectum                                                             magnesemia (Class IIb, LOE C).
    Dialysis
                                                                       Hypomagnesemia
When cardiac arrest occurs secondary to hyperkalemia, it may
                                                                       Hypomagnesemia, defined as a serum magnesium concentration
be reasonable to administer adjuvant IV therapy as outlined
                                                                          1.3 mEq/L, is far more common than hypermagnesemia.
above for cardiotoxicity in addition to standard ACLS (Class IIb,
                                                                       Hypomagnesemia usually results from decreased absorption or
LOE C).
                                                                       increased loss of magnesium from either the kidneys or intes-
ACLS Modifications in Management of Severe                             tines (diarrhea). Alterations in thyroid hormone function, certain
Cardiotoxicity Due to Hypokalemia                                      medications (eg, pentamidine, diuretics, alcohol), and malnour-
Life-threatening hypokalemia is uncommon but can occur in the          ishment can also induce hypomagnesemia.
setting of gastrointestinal and renal losses and is associated with
                                                                       ACLS Modifications in Management of Cardiac Arrest
hypomagnesemia. Severe hypokalemia will alter cardiac tissue
                                                                       and Severe Cardiotoxicity Due to Hypomagnesemia
excitability and conduction. Hypokalemia can produce ECG               Hypomagnesemia can be associated with polymorphic ventric-
changes such as U waves, T-wave flattening, and arrhythmias            ular tachycardia, including torsades de pointes, a pulseless form
(especially if the patient is taking digoxin), particularly ventric-   (polymorphic) of ventricular tachycardia. For cardiotoxicity and
ular arrhythmias,205,206 which, if left untreated, deteriorate to      cardiac arrest, IV magnesium 1 to 2 g of MgSO4 bolus IV push
PEA or asystole.                                                       is recommended (Class I, LOE C).
   Several studies reported an association with hypokalemia and
development of ventricular fibrillation,207–210 whereas a single       Calcium (Ca         )
animal study reported that hypokalemia lowered the ventricular         Calcium abnormality as an etiology of cardiac arrest is rare.
fibrillation threshold.211 However, the management of hypoka-          There are no studies evaluating the treatment of hypercalcemia
lemia in the setting of cardiotoxicity, specifically torsades de       or hypocalcemia during arrest. However, empirical use of
                     Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
S840       Circulation         November 2, 2010


calcium (calcium chloride [10%] 5 to 10 mL OR calcium                  who accompany the patient, evaluation of containers, review of
gluconate [10%] 15 to 30 mL IV over 2 to 5 minutes) may be             pharmacy records, and examination of the patient’s prior med-
considered when hyperkalemia or hypermagnesemia is sus-                ical record.220 Many patients who ingest medications in a suicide
pected as the cause of cardiac arrest (Class IIb, LOE C).              attempt take more than 1 substance, and the number of sub-
                                                                       stances ingested is greater in fatal than in nonfatal suicide
  Part 12.7: Cardiac Arrest Associated With                            attempts.221 Comprehensive toxicology laboratory testing is
               Toxic Ingestions                                        virtually never available in a time frame that supports early
Poisoning has been likened to trauma on the cellular level,            resuscitation decisions.222
destroying the natural workings of a victim’s physiology.218              Poisoned patients may deteriorate rapidly. Care for all adult
Severe poisoning alters the function of a cellular receptor, ion       patients who are critically ill or under evaluation for possible
channel, organelle, or chemical pathway to the extent that critical    toxin exposure or ingestion, particularly when the history is
organ systems can no longer support life.                              uncertain, should begin in a monitored treatment area where the
   As with any patient in cardiac arrest, management of the            development of central nervous system depression, hemody-
patient with a toxic exposure begins with support of airway,           namic instability, or seizures can be rapidly recognized and
breathing, and circulation. Cardiac arrest due to toxicity is          addressed.223
managed in accordance with the current standards of BLS and               Gastrointestinal decontamination, once a mainstay in the
ACLS. With few exceptions, there are no unique antidotes or            management of ingested toxins, has a less significant role in
toxin-specific interventions that are recommended during resus-        poisoning treatment today. With rare exceptions, gastric lavage,
citation from cardiac arrest.                                          whole bowel irrigation, and administration of syrup of ipecac are
   Once return of spontaneous circulation is achieved, urgent          no longer recommended.224 –226 Administration of single-dose
consultation with a medical toxicologist or certified regional         activated charcoal to adsorb ingested toxins is generally recom-
poison center is recommended, as the postarrest management of          mended for the ingestion of life-threatening poisons for which
the critically poisoned patient may benefit from a thorough            no adequate antidotal therapy is available and when the charcoal
understanding of the toxic agent. Consultation is also recom-          can be administered within 1 hour of poisoning.228 Multiple-
mended early in the management of a patient with potentially           dose activated charcoal should be considered for patients who
life-threatening poisoning, when appropriate interventions might       have ingested a life-threatening amount of specific toxins (eg,
prevent deterioration to cardiac arrest. In the United States a        carbamazepine, dapsone, phenobarbital, quinine, or theophyl-
certified poison center can be reached by calling 1-800-222-           line) for which a benefit of this strategy has been established.229
1222; in Canada, call 1-800-268-9017.                                  Charcoal should not be administered for ingestions of caustic
   It is extremely difficult to conduct clinical trials of acute       substances, metals, or hydrocarbons.228
life-threatening poisoning. Challenges include the infrequency            Charcoal should only be administered to patients with an
with which most specific conditions occur, the heterogeneity of        intact or protected airway. In patients who are at risk for
presentation, and ethical challenges related to withholding es-        aspiration, endotracheal intubation and head-of-bed elevation
tablished care from patients who are unable to provide informed        should be performed before charcoal administration.229,230 Be-
consent because the patient has an altered mental status, the          cause the decision to perform gastrointestinal decontamination is
patient is suicidal, or there is a lack of time to explain treatment   complex, multifactorial, and associated with risk, expert advice
alternatives.219                                                       can be helpful.
   The majority of questions addressing cardiac arrest due to
drug toxicity remain unanswered. Epidemiological studies are           Toxidromes
required to document the incidence rate of cardiac arrests             A “toxidrome” is a clinical syndrome—a constellation of signs,
secondary to drug toxicity and the safety and efficacy baseline        symptoms, and laboratory findings—suggestive of the effects of
rates for current therapeutic strategies. This section presents        a specific toxin. By recognizing these presentations, the clinician
recommendations for the care of the patient with a toxicological       can establish a working diagnosis that guides initial manage-
problem causing cardiac arrest or severe cardiovascular instabil-      ment. Some common toxidromes are presented in the Table.
ity (respiratory depression, hypotension, life-threatening alter-      Practically every sign and symptom observed in poisoning
ations of cardiac conduction, etc). Some recommendations are           can be produced by natural disease, and many clinical
evidence-based, but most research in this area consists of case        presentations associated with natural disease can be mim-
reports, small case series, animal studies, and pharmacokinetic        icked by some poison.231 It is important to maintain a
studies in healthy volunteers. Virtually no toxicology research        broad differential diagnosis, particularly when the history
involves human cardiac arrest. Thus, many of these recommen-           of toxic chemical exposure is unclear.
dations are based on expert consensus, and further research is
needed to validate them.                                               Opioid Toxicity
                                                                       There are no data to support the use of specific antidotes in the
Initial Approach to the Critically Poisoned Patient                    setting of cardiac arrest due to opioid overdose. Resuscitation
Management of the critically poisoned patient begins with              from cardiac arrest should follow standard BLS and ACLS
airway protection, support of respiration and circulation, and         algorithms.
rapid assessment. Patients may or may not be able to provide an           Naloxone is a potent antagonist of the binding of opioid
accurate history of exposure to a toxic substance. Whenever            medications to their receptors in the brain and spinal cord.
possible, history gathering should include questioning of persons      Administration of naloxone can reverse central nervous system
                     Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
Vanden Hoek et al              Part 12: Cardiac Arrest in Special Situations              S841


Table.     Common Toxidromes*                                                       Benzodiazepines
                                  Cardiac Signs
                                                                                    There are no data to support the use of specific antidotes in the
                                                                                    setting of cardiac arrest due to benzodiazepine overdose. Resus-
Tachycardia and/or          Bradycardia and/or           Cardiac Conduction         citation from cardiac arrest should follow standard BLS and
Hypertension                Hypotension                  Delays (Wide QRS)          ACLS algorithms.
  Amphetamines                 Beta blockers               Cocaine                     Flumazenil is a potent antagonist of the binding of benzodi-
  Anticholinergic drugs        Calcium channel             Cyclic antidepressants   azepines to their central nervous system receptors. Administra-
                               blockers                                             tion of flumazenil can reverse central nervous system and
  Antihistamines               Clonidine                   Local anesthetics        respiratory depression caused by benzodiazepine overdose.
  Cocaine                      Digoxin and related         Propoxyphene             Flumazenil has no role in the management of cardiac arrest.
                               glycosides                                              The administration of flumazenil to patients with undifferen-
  Theophylline/caffeine        Organophosphates            Antiarrhythmics (e.g.,   tiated coma confers risk and is not recommended (Class III, LOE
                               and carbamates              quinidine, flecainide)   B). Flumazenil administration can precipitate seizures in
Withdrawal states                                                                   benzodiazepine-dependent patients and has been associated with
                                                                                    seizures, arrhythmia, and hypotension in patients with co-
                              CNS/Metabolic Signs
                                                                                    ingestion of certain medications, such as tricyclic antidepres-
                                  CNS and/or Respiratory                            sants.247,248 However, flumazenil may be used safely to
Seizures                          Depression                  Metabolic Acidosis
                                                                                    reverse excessive sedation known to be due to the use of
                                     Antidepressants                                benzodiazepines in a patient without known contraindications
  Cyclic antidepressants             (several classes)           Cyanide
                                                                                    (eg, procedural sedation).249
  Isoniazid                          Benzodiazepines             Ethylene glycol
  Selective and non-selective                                                         -Blockers
  norepinephrine reuptake                                                           There are no data to support the use of specific antidotes in the
  inhibitors (eg, bupropion)         Carbon monoxide             Metformin          setting of cardiac arrest due to -blocker overdose. Resuscitation
  Withdrawal states                  Ethanol                     Methanol           from cardiac arrest should follow standard BLS and ACLS
                                     Methanol                    Salicylates        algorithms.
                                     Opioids                                             -Blocker medication overdose may cause such severe inhi-
                                     Oral hypoglycemics                             bition of -adrenergic receptors that high-dose vasopressors
  *Differential diagnosis lists are partial.
                                                                                    cannot effectively restore blood pressure, cardiac output, or
                                                                                    perfusion. Therapeutic options in the treatment of refractory
                                                                                    hemodynamic instability due to -blocker overdose include
and respiratory depression caused by opioid overdose. Naloxone
                                                                                    administration of glucagon, high-dose insulin, or IV calcium
has no role in the management of cardiac arrest.
   In the patient with known or suspected opioid overdose with                      salts.
respiratory depression who is not in cardiac arrest, ventilation                    Glucagon
should be assisted by a bag mask,232–238 followed by adminis-                       Administration of glucagon may be helpful for severe cardio-
tration of naloxone and placement of an advanced airway if there                    vascular instability associated with -blocker toxicity that is
is no response to naloxone (Class I, LOE A).                                        refractory to standard measures, including vasopressors. The
   Administration of naloxone can produce fulminate opioid                          recommended dose of glucagon is a bolus of 3 to 10 mg,
withdrawal in opioid-dependent individuals, leading to agitation,                   administered slowly over 3 to 5 minutes, followed by an infusion
hypertension, and violent behavior. For this reason, naloxone                       of 3 to 5 mg/h (0.05 to 0.15 mg/kg followed by an infusion of
administration should begin with a low dose (0.04 to 0.4 mg),                       0.05 to 0.10 mg/kg per hour) (Class IIb, LOE C).250 –262 The
with repeat dosing or dose escalation to 2 mg if the initial                        infusion rate is titrated to achieve an adequate hemodynamic
response is inadequate.239 Some patients may require much                           response (appropriate mean arterial pressure and evidence of
higher doses to reverse intoxication with atypical opioids, such                    good perfusion). Because the amount of glucagon required to
as propoxyphene, or following massive overdose inges-                               sustain this therapy may exceed 100 mg in a 24-hour period,
tions.240,241 Naloxone can be given IV,235,236,242,243 IM,232,235,236               plans should be made early to ensure that an adequate supply of
intranasally,232,242 and into the trachea.244                                       glucagon is available. Glucagon commonly causes vomiting. In
   The duration of action of naloxone is approximately 45 to 70                     patients with central nervous system depression, the airway must
minutes, but respiratory depression caused by ingestion of a                        be protected before glucagon administration. Animal studies
long-acting opioid (eg, methadone) may last longer. Thus, the                       have suggested that the concomitant use of dopamine alone or in
clinical effects of naloxone may not last as long as those of the                   combination with isoproterenol and milrinone may decrease the
opioid, and repeat doses of naloxone may be needed.                                 effectiveness of glucagon.263–265
   Patients with life-threatening central nervous system or respi-
ratory depression reversed by naloxone administration should be                     Insulin
observed for resedation. Although a brief period of observation                     Animal studies suggest that high-dose IV insulin, accompanied
may be appropriate for patients with morphine or heroin over-                       by IV dextrose supplementation and electrolyte monitoring, may
dose,245 a longer period of observation may be required to safely                   improve hemodynamic stability and survival in -blocker over-
discharge a patient with life-threatening overdose of a long-                       dose by improving myocardial energy utilization.266,267 A single
acting or sustained-release opioid.239,246                                          human case report268 showed improved hemodynamic stability
                          Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full
S829.full

More Related Content

What's hot

The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treat...
The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treat...The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treat...
The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treat...Nicolas Ugarte
 
Left Ventricular Apical Ballooning, Catecholamine Toxicity, and Cardiomyopathy
Left Ventricular Apical Ballooning, Catecholamine Toxicity, and CardiomyopathyLeft Ventricular Apical Ballooning, Catecholamine Toxicity, and Cardiomyopathy
Left Ventricular Apical Ballooning, Catecholamine Toxicity, and Cardiomyopathyasclepiuspdfs
 
Radiation Associated Cardiac Disease
Radiation Associated Cardiac DiseaseRadiation Associated Cardiac Disease
Radiation Associated Cardiac Diseasemagdy elmasry
 
ST-segment Depression: All are Not Created Equal!
ST-segment Depression: All are Not Created Equal!ST-segment Depression: All are Not Created Equal!
ST-segment Depression: All are Not Created Equal!asclepiuspdfs
 
1. role of cardiac rehabilitation in coronary artery disease
1. role of cardiac rehabilitation in coronary artery disease 1. role of cardiac rehabilitation in coronary artery disease
1. role of cardiac rehabilitation in coronary artery disease farzana khantoon
 
Management della fibrillazione_atriale
Management della fibrillazione_atrialeManagement della fibrillazione_atriale
Management della fibrillazione_atrialeMerqurio
 
Sindromes de falla cardiaca
Sindromes de falla cardiacaSindromes de falla cardiaca
Sindromes de falla cardiacalinaptovar
 
Copd systemic inflammation or systemic manifestations
Copd systemic inflammation or systemic manifestationsCopd systemic inflammation or systemic manifestations
Copd systemic inflammation or systemic manifestationsWaheed Shouman
 
Ueda2016 symposium - central aortic pressure in management hypertension state...
Ueda2016 symposium - central aortic pressure in management hypertension state...Ueda2016 symposium - central aortic pressure in management hypertension state...
Ueda2016 symposium - central aortic pressure in management hypertension state...ueda2015
 
Acute myocardial infarction
Acute myocardial infarctionAcute myocardial infarction
Acute myocardial infarctionhatch_jane
 
Hypertension and its prevention
Hypertension and its prevention Hypertension and its prevention
Hypertension and its prevention DEBOLINA SAHA
 
Acute decompensated heart failure neunschwander
Acute decompensated heart failure neunschwanderAcute decompensated heart failure neunschwander
Acute decompensated heart failure neunschwanderdrucsamal
 
What is heart failure?
What is heart failure?What is heart failure?
What is heart failure?Flora Runyenje
 
Neurogenic shock
Neurogenic shockNeurogenic shock
Neurogenic shockskrentz
 

What's hot (20)

The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treat...
The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treat...The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treat...
The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treat...
 
Left Ventricular Apical Ballooning, Catecholamine Toxicity, and Cardiomyopathy
Left Ventricular Apical Ballooning, Catecholamine Toxicity, and CardiomyopathyLeft Ventricular Apical Ballooning, Catecholamine Toxicity, and Cardiomyopathy
Left Ventricular Apical Ballooning, Catecholamine Toxicity, and Cardiomyopathy
 
Radiation Associated Cardiac Disease
Radiation Associated Cardiac DiseaseRadiation Associated Cardiac Disease
Radiation Associated Cardiac Disease
 
ST-segment Depression: All are Not Created Equal!
ST-segment Depression: All are Not Created Equal!ST-segment Depression: All are Not Created Equal!
ST-segment Depression: All are Not Created Equal!
 
1. role of cardiac rehabilitation in coronary artery disease
1. role of cardiac rehabilitation in coronary artery disease 1. role of cardiac rehabilitation in coronary artery disease
1. role of cardiac rehabilitation in coronary artery disease
 
Management of Shock
Management of ShockManagement of Shock
Management of Shock
 
Management della fibrillazione_atriale
Management della fibrillazione_atrialeManagement della fibrillazione_atriale
Management della fibrillazione_atriale
 
Chapter024management patient with pulmonary disease
Chapter024management patient with pulmonary diseaseChapter024management patient with pulmonary disease
Chapter024management patient with pulmonary disease
 
Sindromes de falla cardiaca
Sindromes de falla cardiacaSindromes de falla cardiaca
Sindromes de falla cardiaca
 
Neurogenic shock
Neurogenic shockNeurogenic shock
Neurogenic shock
 
Stages of shock
Stages of shockStages of shock
Stages of shock
 
Copd systemic inflammation or systemic manifestations
Copd systemic inflammation or systemic manifestationsCopd systemic inflammation or systemic manifestations
Copd systemic inflammation or systemic manifestations
 
Ueda2016 symposium - central aortic pressure in management hypertension state...
Ueda2016 symposium - central aortic pressure in management hypertension state...Ueda2016 symposium - central aortic pressure in management hypertension state...
Ueda2016 symposium - central aortic pressure in management hypertension state...
 
Acute myocardial infarction
Acute myocardial infarctionAcute myocardial infarction
Acute myocardial infarction
 
MANAGEMENT OF SHOCK
MANAGEMENT OF SHOCKMANAGEMENT OF SHOCK
MANAGEMENT OF SHOCK
 
Hypertension and its prevention
Hypertension and its prevention Hypertension and its prevention
Hypertension and its prevention
 
Acute decompensated heart failure neunschwander
Acute decompensated heart failure neunschwanderAcute decompensated heart failure neunschwander
Acute decompensated heart failure neunschwander
 
What is heart failure?
What is heart failure?What is heart failure?
What is heart failure?
 
Advances in resuscitation strategies
Advances in resuscitation strategiesAdvances in resuscitation strategies
Advances in resuscitation strategies
 
Neurogenic shock
Neurogenic shockNeurogenic shock
Neurogenic shock
 

Viewers also liked

01 grace herbosa
01 grace herbosa01 grace herbosa
01 grace herbosaDuy Quang
 
Resuscitation in pregnancy dr.krushna patel
Resuscitation in pregnancy dr.krushna patelResuscitation in pregnancy dr.krushna patel
Resuscitation in pregnancy dr.krushna patelAbdul Sajjad Pathan
 
Resuscitation techniques in pregnancy
Resuscitation techniques in pregnancyResuscitation techniques in pregnancy
Resuscitation techniques in pregnancyEmeka Anugom
 
Anaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhageAnaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhageSasidhar Puvvula
 
Anaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergenciesAnaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergenciesWahid altaf Sheeba hakak
 
Obstetrical emergencies
Obstetrical emergenciesObstetrical emergencies
Obstetrical emergenciesSanil Varghese
 
Obstetrical Anesthesia
Obstetrical AnesthesiaObstetrical Anesthesia
Obstetrical AnesthesiaBitew Mekonnen
 

Viewers also liked (11)

C.V 2016 PED
C.V 2016 PEDC.V 2016 PED
C.V 2016 PED
 
01 grace herbosa
01 grace herbosa01 grace herbosa
01 grace herbosa
 
Resuscitation in pregnancy dr.krushna patel
Resuscitation in pregnancy dr.krushna patelResuscitation in pregnancy dr.krushna patel
Resuscitation in pregnancy dr.krushna patel
 
Resuscitation techniques in pregnancy
Resuscitation techniques in pregnancyResuscitation techniques in pregnancy
Resuscitation techniques in pregnancy
 
Anaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhageAnaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhage
 
Anaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergenciesAnaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergencies
 
Obstetric emergencies
Obstetric emergenciesObstetric emergencies
Obstetric emergencies
 
Obstetrical emergencies
Obstetrical emergenciesObstetrical emergencies
Obstetrical emergencies
 
Obstetrical Anesthesia
Obstetrical AnesthesiaObstetrical Anesthesia
Obstetrical Anesthesia
 
Uterine prolapse
Uterine prolapseUterine prolapse
Uterine prolapse
 
Utero vaginal prolapse
Utero vaginal prolapseUtero vaginal prolapse
Utero vaginal prolapse
 

Similar to S829.full

Anti Hypertensive Drugs Essay
Anti Hypertensive Drugs EssayAnti Hypertensive Drugs Essay
Anti Hypertensive Drugs EssayNicole Savoie
 
Elderly Dehydration Essay Example
Elderly Dehydration Essay ExampleElderly Dehydration Essay Example
Elderly Dehydration Essay ExampleVictoria Barraza
 
Acute Respiratory Failure Research Paper
Acute Respiratory Failure Research PaperAcute Respiratory Failure Research Paper
Acute Respiratory Failure Research PaperChristina Padilla
 
Update on diagnosis and management of emergencies in cardiogenic shock.
Update on diagnosis and management of emergencies in cardiogenic shock. Update on diagnosis and management of emergencies in cardiogenic shock.
Update on diagnosis and management of emergencies in cardiogenic shock. Gustavo Moreno
 
Bridging Trial Case Study
Bridging Trial Case StudyBridging Trial Case Study
Bridging Trial Case StudyNancy Jarjis
 
Pulmonary Rehabilitation Paper
Pulmonary Rehabilitation PaperPulmonary Rehabilitation Paper
Pulmonary Rehabilitation PaperJennifer Reither
 
First Blue Baby Surgery Analysis
First Blue Baby Surgery AnalysisFirst Blue Baby Surgery Analysis
First Blue Baby Surgery AnalysisHeidi Perry
 
Acute Respiratory Failure
Acute Respiratory FailureAcute Respiratory Failure
Acute Respiratory FailureKim Isleb
 
Obstructive Shock, from Diagnosis to Treatment.pdf
Obstructive Shock, from Diagnosis to Treatment.pdfObstructive Shock, from Diagnosis to Treatment.pdf
Obstructive Shock, from Diagnosis to Treatment.pdfJonathanPuente6
 
How Will New Bioabsorbable Polymer Drug Eluting Stents...
How Will New Bioabsorbable Polymer Drug Eluting Stents...How Will New Bioabsorbable Polymer Drug Eluting Stents...
How Will New Bioabsorbable Polymer Drug Eluting Stents...Lindsey Campbell
 
The Anatomy And Physiology Of The Heart
The Anatomy And Physiology Of The HeartThe Anatomy And Physiology Of The Heart
The Anatomy And Physiology Of The HeartSandy Grasso
 
Cardiology: Treatment of Heart Failure
Cardiology: Treatment of Heart FailureCardiology: Treatment of Heart Failure
Cardiology: Treatment of Heart FailureVedica Sethi
 
Evaluation of acute decompensated heart failure2
Evaluation of acute decompensated heart failure2Evaluation of acute decompensated heart failure2
Evaluation of acute decompensated heart failure2drucsamal
 

Similar to S829.full (20)

Anti Hypertensive Drugs Essay
Anti Hypertensive Drugs EssayAnti Hypertensive Drugs Essay
Anti Hypertensive Drugs Essay
 
Elderly Dehydration Essay Example
Elderly Dehydration Essay ExampleElderly Dehydration Essay Example
Elderly Dehydration Essay Example
 
Acute Respiratory Failure Research Paper
Acute Respiratory Failure Research PaperAcute Respiratory Failure Research Paper
Acute Respiratory Failure Research Paper
 
Update on diagnosis and management of emergencies in cardiogenic shock.
Update on diagnosis and management of emergencies in cardiogenic shock. Update on diagnosis and management of emergencies in cardiogenic shock.
Update on diagnosis and management of emergencies in cardiogenic shock.
 
Bridging Trial Case Study
Bridging Trial Case StudyBridging Trial Case Study
Bridging Trial Case Study
 
Cardiogenic shock in emergency medicine
Cardiogenic shock in emergency medicineCardiogenic shock in emergency medicine
Cardiogenic shock in emergency medicine
 
Nacle Physiology
Nacle PhysiologyNacle Physiology
Nacle Physiology
 
Pulmonary Rehabilitation Paper
Pulmonary Rehabilitation PaperPulmonary Rehabilitation Paper
Pulmonary Rehabilitation Paper
 
First Blue Baby Surgery Analysis
First Blue Baby Surgery AnalysisFirst Blue Baby Surgery Analysis
First Blue Baby Surgery Analysis
 
JAHA.119.011991.pdf
JAHA.119.011991.pdfJAHA.119.011991.pdf
JAHA.119.011991.pdf
 
Levosimendan in acs
Levosimendan in acsLevosimendan in acs
Levosimendan in acs
 
Ards(En终)
Ards(En终)Ards(En终)
Ards(En终)
 
Ards(En终)
Ards(En终)Ards(En终)
Ards(En终)
 
Acute Respiratory Failure
Acute Respiratory FailureAcute Respiratory Failure
Acute Respiratory Failure
 
Obstructive Shock, from Diagnosis to Treatment.pdf
Obstructive Shock, from Diagnosis to Treatment.pdfObstructive Shock, from Diagnosis to Treatment.pdf
Obstructive Shock, from Diagnosis to Treatment.pdf
 
How Will New Bioabsorbable Polymer Drug Eluting Stents...
How Will New Bioabsorbable Polymer Drug Eluting Stents...How Will New Bioabsorbable Polymer Drug Eluting Stents...
How Will New Bioabsorbable Polymer Drug Eluting Stents...
 
The Anatomy And Physiology Of The Heart
The Anatomy And Physiology Of The HeartThe Anatomy And Physiology Of The Heart
The Anatomy And Physiology Of The Heart
 
ARDS
ARDSARDS
ARDS
 
Cardiology: Treatment of Heart Failure
Cardiology: Treatment of Heart FailureCardiology: Treatment of Heart Failure
Cardiology: Treatment of Heart Failure
 
Evaluation of acute decompensated heart failure2
Evaluation of acute decompensated heart failure2Evaluation of acute decompensated heart failure2
Evaluation of acute decompensated heart failure2
 

Recently uploaded

Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesMohammad Hassany
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxKatherine Villaluna
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
CAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxCAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxSaurabhParmar42
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphNetziValdelomar1
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptxmary850239
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptxSandy Millin
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17Celine George
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?TechSoup
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxiammrhaywood
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxraviapr7
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...Nguyen Thanh Tu Collection
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice documentXsasf Sfdfasd
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICESayali Powar
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.EnglishCEIPdeSigeiro
 

Recently uploaded (20)

Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming Classes
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
CAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxCAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptx
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a Paragraph
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
3.21.24 The Origins of Black Power.pptx
3.21.24  The Origins of Black Power.pptx3.21.24  The Origins of Black Power.pptx
3.21.24 The Origins of Black Power.pptx
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?
 
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdfPersonal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptx
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice document
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICE
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.
 

S829.full

  • 1. Part 12: Cardiac Arrest in Special Situations : 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Terry L. Vanden Hoek, Laurie J. Morrison, Michael Shuster, Michael Donnino, Elizabeth Sinz, Eric J. Lavonas, Farida M. Jeejeebhoy and Andrea Gabrielli Circulation 2010, 122:S829-S861 doi: 10.1161/CIRCULATIONAHA.110.971069 Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX 72514 Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online ISSN: 1524-4539 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://circ.ahajournals.org/content/122/18_suppl_3/S829 An erratum has been published regarding this article. Please see the attached page for: http://circ.ahajournals.org/ Subscriptions: Information about subscribing to Circulation is online at http://circ.ahajournals.org//subscriptions/ Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Fax: 410-528-8550. E-mail: journalpermissions@lww.com Reprints: Information about reprints can be found online at http://www.lww.com/reprints Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 2. Part 12: Cardiac Arrest in Special Situations 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Terry L. Vanden Hoek, Chair; Laurie J. Morrison; Michael Shuster; Michael Donnino; Elizabeth Sinz; Eric J. Lavonas; Farida M. Jeejeebhoy; Andrea Gabrielli T his section of the 2010 AHA Guidelines for CPR and ECC addresses cardiac arrest in situations that require special treatments or procedures beyond those provided Pathophysiology The pathophysiology of asthma consists of 3 key abnormalities: ● Bronchoconstriction during basic life support (BLS) and advanced cardiovas- ● Airway inflammation cular life support (ACLS). We have included 15 specific cardiac arrest situations. The first several sections discuss ● Mucous plugging cardiac arrest associated with internal physiological or Complications of severe asthma, such as tension pneumo- metabolic conditions, such as asthma (12.1), anaphylaxis thorax, lobar atelectasis, pneumonia, and pulmonary edema, (12.2), pregnancy (12.3), morbid obesity (12.4), pulmo- can contribute to fatalities. Severe asthma exacerbations are nary embolism (PE) (12.5), and electrolyte imbalance commonly associated with hypercarbia and acidemia, hypo- (12.6). tension due to decreased venous return, and depressed mental The next several sections relate to resuscitation and treat- status, but the most common cause of death is asphyxia. ment of cardiac arrest associated with external or environ- mentally related circumstances, such as ingestion of toxic Cardiac causes of death are less common.4 substances (12.7), trauma (12.8), accidental hypothermia (12.9), avalanche (12.10), drowning (12.11), and electric Clinical Aspects of Severe Asthma shock/lightning strikes (12.12). Wheezing is a common physical finding, although the sever- The last 3 sections review management of cardiac arrest ity of wheezing does not correlate with the degree of airway that may occur during special situations affecting the heart, obstruction. The absence of wheezing may indicate critical including percutaneous coronary intervention (PCI) (12.13), airway obstruction, whereas increased wheezing may indicate cardiac tamponade (12.14), and cardiac surgery (12.15). a positive response to bronchodilator therapy. Oxygen saturation (SaO2) levels may not reflect progressive Part 12.1: Cardiac Arrest Associated alveolar hypoventilation, particularly if oxygen is being admin- With Asthma istered. Note that SaO2 may fall initially during therapy because Asthma is responsible for more than 2 million visits to the 2-agonists produce both bronchodilation and vasodilation and emergency department (ED) in the United States each year, initially may increase intrapulmonary shunting. with 1 in 4 patients requiring admission to a hospital.1 Other causes of wheezing are pulmonary edema,5 chronic Annually there are 5,000 to 6,000 asthma-related deaths in obstructive pulmonary disease (COPD), pneumonia, anaphyl- the United States, many occurring in the prehospital axis,6 foreign bodies, PE, bronchiectasis, and subglottic mass.7 setting.2 Severe asthma accounts for approximately 2% to 20% of admissions to intensive care units, with up to one Initial Stabilization third of these patients requiring intubation and mechanical Patients with severe life-threatening asthma require urgent ventilation.3 This section focuses on the evaluation and and aggressive treatment with simultaneous administration of treatment of patients with near-fatal asthma. oxygen, bronchodilators, and steroids. Healthcare providers Several consensus groups have developed excellent guide- must monitor these patients closely for deterioration. Al- lines for the management of asthma that are available on the World Wide Web: though the pathophysiology of life-threatening asthma con- sists of bronchoconstriction, inflammation, and mucous plug- ● http://www.nhlbi.nih.gov/about/naepp ging, only bronchoconstriction and inflammation are ● http://www.ginasthma.com amenable to drug treatment. The American Heart Association requests that this document be cited as follows: Vanden Hoek TL, Morrison LJ, Shuster M, Donnino M, Sinz E, Lavonas EJ, Jeejeebhoy FM, Gabrielli A. Part 12: cardiac arrest in special situations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122(suppl 3):S829 –S861. (Circulation. 2010;122[suppl 3]:S829 –S861.) © 2010 American Heart Association, Inc. Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.110.971069 Downloaded from http://circ.ahajournals.org/S829 MED CTR BOISE on September 29, 2011 at VA
  • 3. S830 Circulation November 2, 2010 Primary Therapy minutes and no systemic side effects. The drug is typically given Oxygen only once because of its prolonged onset of action, but some Oxygen should be provided to all patients with severe asthma, studies have shown that repeat doses of 250 mcg or 500 mcg even those with normal oxygenation. As noted above, successful every 20 minutes may be beneficial.17 A recent meta-analysis treatment with 2-agonists may cause an initial decrease in indicated a reduced number of hospital admissions associated oxygen saturation because the resultant bronchodilation can with treatment with ipratropium bromide, particularly in patients initially increase the ventilation-perfusion mismatch. with severe exacerbations.18 Inhaled 2-Agonists Magnesium Sulfate Short-acting -agonists provide rapid, dose-dependent bron- When combined with nebulized -adrenergic agents and corti- chodilation with minimal side effects. Because the dose deliv- costeroids, IV magnesium sulfate can moderately improve pul- ered depends on the patient’s lung volume and inspiratory flow monary function in patients with asthma.19 Magnesium causes rate, the same dose can be used in most patients regardless of age relaxation of bronchial smooth muscle independent of serum or size. Studies have shown no difference in the effects of magnesium level, with only minor side effects (flushing, light- continuous versus intermittent administration of nebulized albu- headedness). A Cochrane meta-analysis of 7 studies concluded terol8,9; however, continuous administration was more effective that IV magnesium sulfate improves pulmonary function and in a subset of patients with severe exacerbations of asthma.8 A reduces hospital admissions, particularly for patients with the Cochrane meta-analysis showed no overall difference between most severe exacerbations of asthma.20 The use of nebulized the effects of albuterol delivered by metered-dose inhaler spacer magnesium sulfate as an adjunct to nebulized -adrenergic or nebulizer.10 If prior use of a metered-dose inhaler has not been agents has been reported in a small case series to improve FEV1 effective, use of a nebulizer is reasonable. and SpO2,21 although a prior meta-analysis demonstrated only a Although albuterol is sometimes administered intravenously trend toward improved pulmonary function with nebulized (IV) in severe asthma, a systematic review of 15 clinical trials magnesium.22 For those with severe refractory asthma, providers found that IV 2-agonists, administered by either bolus or may consider IV magnesium at the standard adult dose of 2 g infusion, did not lead to significant improvements in any clinical administered over 20 minutes. outcome measure.9 Epinephrine or Terbutaline Levalbuterol is the R-isomer of albuterol. Comparisons with Epinephrine and terbutaline are adrenergic agents that can be albuterol have produced mixed results, with some studies show- given subcutaneously to patients with acute severe asthma. The ing a slightly improved bronchodilator effect in the treatment of dose of subcutaneous epinephrine (concentration 1:1000) is 0.01 acute asthma in the ED.11 There is no evidence that levalbuterol mg/kg, divided into 3 doses of approximately 0.3 mg adminis- should be favored over albuterol. tered at 20-minute intervals. Although the nonselective adrener- One of the most common adjuncts used with -agonist gic properties of epinephrine may cause an increase in heart rate, treatment, particularly in the first hours of treatment, include myocardial irritability, and increased oxygen demand, its use is anticholinergic agents (see “Adjunctive Therapies” below for well-tolerated, even in patients 35 years of age.23 Terbutaline more detail). When combined with short-acting -agonists, is given in a subcutaneous dose of 0.25 mg, which can be anticholinergic agents such as ipratropium can produce a repeated every 20 minutes for 3 doses. There is no evidence that clinically modest improvement in lung function compared subcutaneous epinephrine or terbutaline has advantages over with short-acting -agonists alone.12,13 inhaled 2-agonists. Epinephrine has been administered IV (initiated at 0.25 mcg/min to 1 mcg/min continuous infusion) in Corticosteroids Systemic corticosteroids are the only treatment for the inflam- severe asthma; however, 1 retrospective investigation indicated a matory component of asthma proven to be effective for acute 4% incidence of serious side effects. There is no evidence of asthma exacerbations. Because the antiinflammatory effects improved outcomes with IV epinephrine compared with selec- after administration may not be apparent for 6 to 12 hours, tive inhaled 2-agonists.24 corticosteroids should be administered early. The early use of Ketamine systemic steroids hastens the resolution of airflow obstruction Ketamine is a parenteral, dissociative anesthetic with bronchodi- and may reduce admission to the hospital.14 Although there may latory properties that also can stimulate copious bronchial be no difference in clinical effects between oral and IV formu- secretions. One case series25 suggested substantial efficacy, lations of corticosteroids,15,16 the IV route is preferable in whereas 2 published randomized trials in children26,27 found no patients with severe asthma. In adults a typical initial dose of benefit of ketamine when compared with standard care. Keta- methylprednisolone is 125 mg (dose range: 40 mg to 250 mg); mine has sedative and analgesic properties that may be useful if a typical dose of dexamethasone is 10 mg. intubation is planned. Adjunctive Therapies Heliox Anticholinergics Heliox is a mixture of helium and oxygen (usually a 70:30 Ipratropium bromide is an anticholinergic bronchodilator phar- helium to oxygen ratio mix) that is less viscous than ambient air. macologically related to atropine. The nebulizer dose is 500 Heliox has been shown to improve the delivery and deposition mcg.15,16 Ipratropium bromide has a slow onset of action of nebulized albuterol28; however, a recent meta-analysis of (approximately 20 minutes), with peak effectiveness at 60 to 90 clinical trials did not support its use as initial treatment for Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 4. Vanden Hoek et al Part 12: Cardiac Arrest in Special Situations S831 patients with acute asthma.29 Because the heliox mixture re- provider should use the largest endotracheal tube available quires at least 70% helium for effect, it cannot be used if the (usually 8 or 9 mm) to decrease airway resistance. Immediately patient requires 30% oxygen. after intubation, endotracheal tube placement should be con- firmed by clinical examination and waveform capnography. A Methylxanthines Although once considered a mainstay in the treatment of acute chest radiograph should then be performed. asthma, methylxanthines are no longer recommended because of their erratic pharmacokinetics, known side effects, and lack of Troubleshooting After Intubation evidence of benefit.30 When severe bronchoconstriction is present, breath stacking (so-called auto-PEEP) can develop during positive-pressure Leukotriene Antagonists ventilation, leading to complications such as hyperinflation, Leukotriene antagonists improve lung function and decrease the tension pneumothorax, and hypotension. During manual or need for short-acting 2-agonists for long-term asthma therapy, mechanical ventilation, a slower respiratory rate should be used but their effectiveness during acute exacerbations of asthma is with smaller tidal volumes (eg, 6 to 8 mL/kg),36 shorter inspira- unproven. tory time (eg, adult inspiratory flow rate 80 to 100 mL/min), and Inhaled Anesthetics longer expiratory time (eg, inspiratory to expiratory ratio 1:4 or Case reports in adults31 and children32 suggest a benefit of the 1:5) than generally would be provided to patients without potent inhalation anesthetics sevoflurane and isoflurane for asthma.37 Management of mechanical ventilation will vary patients with life-threatening asthma unresponsive to maximal based on patient-ventilation characteristics. Expert consultation conventional therapy. These agents may have direct bronchodi- should be obtained. lator effects. In addition, the anesthetic effect of these drugs Mild hypoventilation (permissive hypercapnia) reduces the increases the ease of mechanical ventilation and reduces oxygen risk of barotrauma. Hypercapnia is typically well tolerated.38,39 demand and carbon dioxide production. This therapy requires Sedation is often required to optimize ventilation, decrease expert consultation in an intensive care setting, and its effective- ventilator dyssynchrony (and therefore auto-PEEP), and mini- ness has not been evaluated in randomized clinical studies. mize barotrauma after intubation. Because delivery of inhaled medications may be inadequate before intubation, the provider Assisted Ventilation should continue to administer inhaled albuterol treatments Noninvasive Positive-Pressure Ventilation through the endotracheal tube. Noninvasive positive-pressure ventilation (NIPPV) may offer Four common causes of acute deterioration in any intubated short-term support for patients with acute respiratory failure and patient are recalled by the mnemonic DOPE (tube Displace- may delay or eliminate the need for endotracheal intuba- ment, tube Obstruction, Pneumothorax, Equipment failure). tion.33–35 This therapy requires that the patient is alert and has Auto-PEEP is another common cause of deterioration in patients adequate spontaneous respiratory effort. Bilevel positive with asthma. If the asthmatic patient’s condition deteriorates or airway pressure (BiPAP), the most common method of delivering NIPPV, allows for separate control of inspiratory if it is difficult to ventilate the patient, check the ventilator for and expiratory pressures. leaks or malfunction; verify endotracheal tube position; elimi- nate tube obstruction (eliminate any mucous plugs and kinks); Endotracheal Intubation With Mechanical Ventilation evaluate for auto-PEEP; and rule out a pneumothorax. Endotracheal intubation is indicated for patients who present High-end expiratory pressure can be reduced quickly by with apnea, coma, persistent or increasing hypercapnia, exhaus- separating the patient from the ventilator circuit; this will allow tion, severe distress, and depression of mental status. Clinical PEEP to dissipate during passive exhalation. If auto-PEEP judgment is necessary to assess the need for immediate endo- results in significant hypotension, assisting with exhalation by tracheal intubation for these critically ill patients. Endotracheal pressing on the chest wall after disconnection of the ventilator intubation does not solve the problem of small airway constric- circuit will allow active exhalation and should lead to immediate tion in patients with severe asthma; thus, therapy directed toward resolution of hypotension. To minimize auto-PEEP, decrease the relief of bronchoconstriction should be continued. Mechanical respiratory rate or tidal volume or both. If auto-PEEP persists ventilation in the asthmatic patient can be difficult and associ- ated risks require careful management. Intubation and positive- and the patient displays ventilator dyssynchrony despite ade- pressure ventilation can trigger further bronchoconstriction and quate sedation, paralytic agents may be considered. complications such as breath stacking that result from incom- In exceedingly rare circumstances, aggressive treatment for plete expiration, air trapping, and buildup of positive end- acute respiratory failure due to severe asthma will not provide expiratory pressure (ie, intrinsic or auto-PEEP). This breath adequate gas exchange. There are case reports that describe stacking can cause barotrauma. Decreasing tidal volume may successful use of extracorporeal membrane oxygenation avoid auto-PEEP and high peak airway pressures. Optimal (ECMO) in adult and pediatric patients40 – 43 with severe asthma ventilator management requires expert consultation and ongoing after other aggressive measures have failed to reverse hyoxemia careful review of ventilation flow and pressure curves. Although and hypercarbia. endotracheal intubation introduces risks, it should be performed when necessary based on clinical condition. BLS Modifications Rapid sequence intubation is the technique of choice and BLS treatment of cardiac arrest in asthmatic patients is should be performed by an expert in airway management. The unchanged. Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 5. S832 Circulation November 2, 2010 ACLS Modifications to cardiac arrest.61,62 Myocardial ischemia and acute myocardial When cardiac arrest occurs in the patient with acute asthma, infarction, malignant arrhythmias, and cardiovascular depression standard ACLS guidelines should be followed. can also contribute to rapid hemodynamic deterioration and Case series and case reports describe a novel technique of cardiac arrest.63 Additionally, cardiac dysfunction may result cardiopulmonary resuscitation (CPR) termed “lateral chest com- from underlying disease or development of myocardial ischemia pressions”; however, there is insufficient evidence to recom- due to hypotension or following administration of mend this technique over standard techniques.44 –50 epinephrine.64,65 The adverse effect of auto-PEEP on coronary perfusion There are no randomized controlled trials evaluating alterna- pressure and capacity for successful defibrillation has been tive treatment algorithms for cardiac arrest due to anaphylaxis. described in patients in cardiac arrest without asthma.51,52 More- Evidence is limited to case reports and extrapolations from over, the adverse effect of auto-PEEP on hemodynamics in nonfatal cases, interpretation of pathophysiology, and consensus asthmatic patients who are not in cardiac arrest has also been opinion. Providers must be aware that urgent support of airway, well-described.53–56 Therefore, since the effects of auto-PEEP in breathing, and circulation is essential in suspected anaphylactic an asthmatic patient with cardiac arrest are likely quite severe, a reactions. ventilation strategy of low respiratory rate and tidal volume is Because of limited evidence, the management of cardiac reasonable (Class IIa, LOE C). During arrest a brief disconnec- arrest secondary to anaphylaxis should be treated with standard tion from the bag mask or ventilator may be considered, and BLS and ACLS. The following therapies are largely consensus- compression of the chest wall to relieve air-trapping can be based but commonly used and widely accepted in the manage- effective (Class IIa, LOE C). ment of the patient with anaphylaxis who is not in cardiac arrest. For all asthmatic patients with cardiac arrest, and especially for patients in whom ventilation is difficult, the possible diag- BLS Modifications nosis of a tension pneumothorax should be considered and Airway treated (Class I, LOE C). Early and rapid advanced airway management is critical and should not be unnecessarily delayed. Given the potential for the Part 12.2: Cardiac Arrest Associated rapid development of oropharyngeal or laryngeal edema,66 With Anaphylaxis immediate referral to a health professional with expertise in Anaphylaxis is an allergic reaction characterized by multisystem advanced airway placement is recommended (Class I, LOE C). involvement, including skin, airway, vascular system, and gas- trointestinal tract. Severe cases may result in complete obstruc- Circulation tion of the airway and cardiovascular collapse from vasogenic The intramuscular (IM) administration of epinephrine (epineph- shock. Anaphylaxis accounts for about 500 to 1000 deaths per rine autoinjectors, eg, the EpiPen™) in the anterolateral aspect year in the United States.57 of the middle third of the thigh provides the highest peak blood The term classic anaphylaxis refers to hypersensitivity reac- levels.67 Absorption and subsequent achievement of maximum tions mediated by the immunoglobulins IgE and IgG. Prior plasma concentration after subcutaneous administration is sensitization to an allergen produces antigen-specific immuno- slower than the IM route and may be significantly delayed with globulins. Subsequent reexposure to the allergen provokes the shock.67 anaphylactic reaction, although many anaphylactic reactions Epinephrine68 should be administered early by IM injection to occur with no documented prior exposure. Pharmacological all patients with signs of a systemic allergic reaction, especially agents, latex, foods, and stinging insects are among the most hypotension, airway swelling, or difficulty breathing (Class I, common causes of anaphylaxis described. LOE C). The recommended dose is 0.2 to 0.5 mg (1:1000) IM to be repeated every 5 to 15 minutes in the absence of clinical Signs and Symptoms improvement (Class I, LOE C).69 The adult epinephrine IM The initial symptoms of anaphylaxis are often nonspecific auto-injector will deliver 0.3 mg of epinephrine and the pediatric and include tachycardia, faintness, cutaneous flushing, urti- epinephrine IM auto-injector will deliver 0.15 mg of epineph- caria, diffuse or localized pruritus, and a sensation of impend- rine. In both anaphylaxis and cardiac arrest the immediate use of ing doom. Urticaria is the most common physical finding. an epinephrine autoinjector is recommended if available (Class I, The patient may be agitated or anxious and may appear either LOE C). flushed or pale. A common early sign of respiratory involvement is rhinitis. ACLS Modifications As respiratory compromise becomes more severe, serious upper Airway airway (laryngeal) edema may cause stridor and lower airway Early recognition of the potential for a difficult airway in edema (asthma) may cause wheezing. Upper airway edema can anaphylaxis is paramount in patients who develop hoarseness, also be a sign in angiotensin converting enzyme inhibitor- lingual edema, stridor, or oropharyngeal swelling. Planning for induced angioedema or C1 esterase inhibitor deficiency with advanced airway management, including a surgical airway,70 is spontaneous laryngeal edema.58 – 60 recommended (Class I, LOE C). Cardiovascular collapse is common in severe anaphylaxis. If not promptly corrected, vasodilation and increased capillary Fluid Resuscitation permeability, causing decreased preload and relative hypovole- In a prospective evaluation of volume resuscitation after diag- mia of up to 37% of circulating blood volume, can rapidly lead nostic sting challenge, repeated administration of 1000-mL Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 6. Vanden Hoek et al Part 12: Cardiac Arrest in Special Situations S833 bolus doses of isotonic crystalloid (eg, normal saline) titrated to these advanced techniques may be considered in clinical situa- systolic blood pressure above 90 mm Hg was used successfully tions where the required professional skills and equipment are in patients whose hypotension did not respond immediately to immediately available (Class IIb, LOE C). vasoactive drugs.61,71 Vasogenic shock from anaphylaxis may require aggressive fluid resuscitation (Class IIa, LOE C). Part 12.3: Cardiac Arrest Associated With Pregnancy Vasopressors There are no human trials establishing the role of epinephrine or Scope of the Problem preferred route of administration in anaphylactic shock managed The Confidential Enquiries into Maternal and Child Health by ACLS providers.68 In an animal study of profound anaphy- (CEMACH) data set constitutes the largest population-based lactic shock, IV epinephrine restored blood pressure to baseline; data set on this target population.92 The overall maternal mor- however, the effect was limited to the first 15 minutes after tality rate was calculated at 13.95 deaths per 100 000 materni- shock, and no therapeutic effect was observed with the same ties. There were 8 cardiac arrests with a frequency calculated at dose of epinephrine administered IM or subcutaneously.72 0.05 per 1000 maternities, or 1:20 000. The frequency of cardiac Therefore, when an IV line is in place, it is reasonable to arrest in pregnancy is on the rise with previous reports estimating consider the IV route as an alternative to IM administration of the frequency to be 1:30 000 maternities.93 Despite pregnant epinephrine in anaphylactic shock (Class IIa, LOE C). women being younger than the traditional cardiac arrest patient, For patients not in cardiac arrest, IV epinephrine 0.05 to 0.1 the survival rates are poorer, with one case series reporting a mg (5% to 10% of the epinephrine dose used routinely in cardiac survival rate of 6.9%.93,94 arrest) has been used successfully in patients with anaphylactic During attempted resuscitation of a pregnant woman, provid- shock.73 Because fatal overdose of epinephrine has been repo- ers have 2 potential patients: the mother and the fetus. The best rted,64,71,74,75 close hemodynamic monitoring is recommended hope of fetal survival is maternal survival. For the critically ill (Class I, LOE B). pregnant patient, rescuers must provide appropriate resuscitation In a study of animals sensitized by ragweed, a continuous IV based on consideration of the physiological changes caused by infusion of epinephrine maintained a mean arterial pressure at pregnancy. 70% of preshock levels better than no treatment or bolus epinephrine treatment (IV, subcutaneous, or IM).76 Furthermore, Key Interventions to Prevent Arrest The following interventions are the standard of care for a recent human study suggests that careful titration of a contin- treating the critically ill pregnant patient (Class I, LOE C): uous infusion of IV epinephrine (5 to 15 mcg/min), based on severity of reaction and in addition to crystalloid infusion, may ● Place the patient in the full left-lateral position to relieve be considered in treatment of anaphylactic shock.71 Therefore, possible compression of the inferior vena cava. Uterine IV infusion of epinephrine is a reasonable alternative to IV obstruction of venous return can produce hypotension and boluses for treatment of anaphylaxis in patients not in cardiac may precipitate arrest in the critically ill patient.95,96 arrest (Class IIa, LOE C) and may be considered in postarrest ● Give 100% oxygen. management (Class IIb, LOE C). ● Establish intravenous (IV) access above the diaphragm. Recently vasopressin has been used successfully in patients ● Assess for hypotension; maternal hypotension that war- with anaphylaxis (with or without cardiac arrest) who did not rants therapy has been defined as a systolic blood pressure respond to standard therapy.77–79 Other small case series de- 100 mm Hg or 80% of baseline.97,98 Maternal hypo- scribed successful results with administration of alternative tension can result in reduced placental perfusion.99 –102 In -agonists such as norepinephrine,80 methoxamine,81,82 and the patient who is not in arrest, both crystalloid and colloid metaraminol.83– 85 Alternative vasoactive drugs (vasopressin, solutions have been shown to increase preload.103 norepinephrine, methoxamine, and metaraminol) may be ● Consider reversible causes of critical illness and treat considered in cardiac arrest secondary to anaphylaxis that conditions that may contribute to clinical deterioration as does not respond to epinephrine (Class IIb, LOE C). No early as possible. randomized controlled trials have evaluated epinephrine ver- sus the use of alternative vasoactive drugs for cardiac arrest Resuscitation of the Pregnant Patient in Cardiac due to anaphylaxis. Arrest (Figure 1) There are no randomized controlled trials evaluating the effect of Other Interventions specialized obstetric resuscitation versus standard care in preg- There are no prospective randomized clinical studies evaluating nant patients in cardiac arrest. There are reports in the literature the use of other therapeutic agents in anaphylactic shock or of patients not in arrest that describe the science behind impor- cardiac arrest. Adjuvant use of antihistamines (H1 and H2 tant physiological changes that occur in pregnancy that may antagonist),86,87 inhaled -adrenergic agents,88 and IV cortico- influence treatment recommendations and guidelines for resus- steroids89 has been successful in management of the patient with citation from cardiac arrest in pregnancy. anaphylaxis and may be considered in cardiac arrest due to anaphylaxis (Class IIb, LOE C). BLS Modifications Extracorporeal Support of Circulation Patient Positioning Cardiopulmonary bypass has been successful in isolated case Patient position has emerged as an important strategy to improve reports of anaphylaxis followed by cardiac arrest.90,91 Use of the quality of CPR and resultant compression force and output. Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 7. S834 Circulation November 2, 2010 Figure 1. Maternal cardiac arrest algorithm. The pregnant uterus can compress the inferior vena cava, Two studies in pregnant women not in arrest found that impeding venous return and thereby reducing stroke volume and manual left uterine displacement, which is done with the patient cardiac output. Reports of noncardiac arrest parturients indicate supine, is as good as or better than left-lateral tilt in relieving that left-lateral tilt results in improved maternal hemodynamics aortocaval compression (as assessed by the incidence of hypo- of blood pressure, cardiac output, and stroke volume96,98,104; and tension and use of ephedrine).111,112 improved fetal parameters of oxygenation, nonstress test, and Therefore, to relieve aortocaval compression during chest fetal heart rate.100 –102 compressions and optimize the quality of CPR, it is reasonable Although chest compressions in the left-lateral tilt position are to perform manual left uterine displacement in the supine feasible in a manikin study,105 they result in less forceful chest position first (Class IIa, LOE C). Left uterine displacement can compressions than are possible in the supine position.106 Two be performed from either the patient’s left side with the studies found no improvement in maternal hemodynamic or fetal 2-handed technique (Figure 2) or the patient’s right side with the parameters with 10° to 20° left-lateral tilt in patients not in 1-handed technique (Figure 3), depending on the positioning of arrest.107,108 One study reported more aortic compression at 15° the resuscitation team. If this technique is unsuccessful, and an left-lateral tilt compared with a full left-lateral tilt.97 In addition, appropriate wedge is readily available, then providers may aortic compression has been found at 30° of tilt,109 however consider placing the patient in a left-lateral tilt of 27° to 30°,106 the majority of these patients were in labor. using a firm wedge to support the pelvis and thorax (Figure 4) If left-lateral tilt is used to improve maternal hemodynamics (Class IIb, LOE C). during cardiac arrest, the degree of tilt should be maximized. If chest compressions remain inadequate after lateral uterine However, at a tilt 30° the patient may slide or roll off the displacement or left-lateral tilt, immediate emergency cesarean section should be considered. (See “Emergency Cesarean Sec- inclined plane,106 so this degree of tilt may not be practical tion in Cardiac Arrest,” below.) during resuscitation. Although important, the degree of tilt is difficult to estimate reliably; 1 study reported that the degree of Airway table tilt is often overestimated.110 Using a fixed, hard wedge of Airway management is more difficult during pregnancy a predetermined angle may help. (see “ACLS Modifications: Airway,” below), and placing the Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 8. Vanden Hoek et al Part 12: Cardiac Arrest in Special Situations S835 Figure 2. . Left uterine displacement with 2-handed technique. Figure 4. Patient in a 30° left-lateral tilt using a firm wedge to patient in a tilt may increase the difficulty. In addition, altered support pelvis and thorax. airway anatomy increases the risks of aspiration and rapid desaturation. Therefore, optimal use of bag-mask ventilation of the diaphragm and abdominal contents caused by the gravid and suctioning, while preparing for advanced airway place- uterus. ment (see “ACLS Modifications”) is critical. Defibrillation Breathing Use of an AED on a pregnant victim has not been studied but is Pregnant patients can develop hypoxemia rapidly because of reasonable. decreased functional residual capacity and increased oxygen demand. One study in normal pregnancy reported increased ACLS Modifications intrapulmonary shunting of 12.8% to 15.3% compared with the There should be no delay in delivering usual treatments during nonpregnant state, in which the normal value is 2% to 5%,113 the management of cardiac arrest in pregnancy. which further increases the risk of hypoxemia. Ventilation volumes may need to be reduced because the mother’s dia- Airway phragm is elevated. Providers should be prepared to support Pregnancy results in changes in airway mucosa, including oxygenation and ventilation and monitor oxygen saturation edema, friability, hypersecretion, and hyperemia.114,115 In addi- closely. tion, 1 study found that the upper airway in the third trimester of pregnancy is smaller compared with that of nonpregnant women Circulation and women in the postpartum period.116 Therefore, airway Chest compressions should be performed slightly higher on the management of the pregnant patient may be more difficult than sternum than normally recommended to adjust for the elevation airway management of the nonpregnant patient. There is significant literature recognizing the issue of failed intubation in obstetric anesthesia as a major cause of maternal morbidity and mortality.117,118 All providers involved in a resuscitation attempt should be aware of the increased risk for pregnancy-related complications in airway management. Intuba- tion with an endotracheal tube or supraglottic airway should be performed only by experienced providers if possible. Cheun et al119 found that during apnea desaturation in pregnant patients is significantly faster than in nonpreg- nant patients. Bag-mask ventilation with 100% oxygen before intubation is especially important in pregnancy (Class IIa, LOE B).120 Circulation Changes in Pharmacokinetics One clinical pharmacokinetic study discovered an increase in the rate of glomerular filtration and volume of plasma during normal Figure 3. Left uterine displacement using 1-handed technique. pregnancy.121 There is no evidence, however, that current Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 9. S836 Circulation November 2, 2010 medications or doses should be altered during management of fibrinolytics are relatively contraindicated in pregnancy, PCI is cardiac arrest in pregnancy; therefore, current recommended the reperfusion strategy of choice for ST-elevation myocardial drug dosages for use in resuscitation of adults should also be infarction. used in resuscitation of the pregnant patient. The number of babies born with congenital heart disease who now survive to adulthood has increased exponentially over the Defibrillation last 3 decades.139,140 It is estimated that 85% of neonates born Defibrillation should be performed at the recommended with congenital heart disease will survive to adulthood. There- ACLS defibrillation doses (Class I, LOE C).122 fore, more women with congenital heart disease are surviving to Although there are no studies documenting maternal or fetal have children, which translates into higher risk for a cardiac complications with defibrillation, there are case reports123–130 event during pregnancy. In fact, illnesses related to congenital and case series131–133 that describe potential harm to the fetus heart disease and pulmonary hypertension are the third most when an accidental electric shock (lightning, electric circuit) is common cause of maternal cardiac deaths.92 delivered directly to the mother. After a pregnant woman receives an electric shock, the range of clinical presentations Magnesium Sulfate Toxicity varies from the mother feeling only a strange sensation with no Patients with magnesium toxicity present with cardiac effects fetal effects to fetal death either immediately or a few days after ranging from ECG interval changes (prolonged PR, QRS and the shock. Risk factors for adverse fetal outcomes include the QT intervals) at magnesium levels of 2.5–5 mmol/L to AV nodal magnitude of current and duration of contact. The greatest conduction block, bradycardia, hypotension and cardiac arrest at predictor of risk for adverse fetal outcome is if the current travels levels of 6 –10 mmol/L. Neurological effects ranging from loss through the uterus, because amniotic fluid most likely transmits of tendon reflexes, sedation, severe muscular weakness, and current in a manner similar to that transmitted via other body respiratory depression are seen at levels of 4 –5 mmol/L. Other fluids, which could increase the risk of fetal death or burns. signs of magnesium toxicity include gastrointestinal symptoms Although there is a small risk of inducing fetal arrhythmias, (nausea and vomiting), skin changes (flushing), and electrolyte/ cardioversion and defibrillation on the external chest are consid- fluid abnormalities (hypophosphatemia, hyperosmolar dehydra- ered safe at all stages of pregnancy.134 –136 tion). Patients with renal failure and metabolic derangements can Some experts have raised concern that electric arcing may develop toxicity after relatively lower magnesium doses. occur if fetal monitors are attached during defibrillation of a Iatrogenic overdose is possible in the pregnant woman who pregnant woman, but there is no evidence to support this. receives magnesium sulfate, particularly if the woman becomes Overall it is reasonable to assume that if the shock is delivered oliguric. Empirical calcium administration may be lifesaving in to the mother’s thorax, there is very low to no risk of electric these cases.141–143 arcing to fetal monitors. If internal or external fetal monitors are attached during cardiac arrest in a pregnant woman, it is Preeclampsia/Eclampsia reasonable to remove them (Class IIb, LOE C). Preeclampsia/eclampsia develops after the 20th week of gesta- tion and can produce severe hypertension and ultimately diffuse Treatment of Reversible Causes organ-system failure. If untreated, maternal and fetal morbidity The same reversible causes of cardiac arrest that occur in and mortality may result. nonpregnant women can occur during pregnancy. Providers Life-Threatening Pulmonary Embolism (PE) should be familiar with pregnancy-specific diseases and proce- Successful use of fibrinolytics in pregnant women has been dural complications and during resuscitation attempts should try reported for massive, life-threatening PE144 –146 and ische- to identify common and reversible causes of cardiac arrest in mic stroke.147 Pregnant women in cardiac arrest with pregnancy.92 suspected PE should be treated in accordance with the Cardiac Disease ACLS guidelines (see Part 12.5: “Cardiac Arrest Associ- Cardiac disease is the primary cause of maternal mortality, ated With Pulmonary Embolism”). according to the 2003 to 2005 Confidential Enquiries into Amniotic Fluid Embolism Maternal and Child Health report.92 For example, the number of Clinicians have reported successful use of cardiopulmonary deaths from cardiac disease was 2.27 per 100,000 pregnancies, bypass for pregnant women with a life-threatening amniotic whereas the number of deaths from thrombosis and thrombo- fluid embolism during labor and delivery.148 The use of peri- embolism was 1.94 per 100,000 pregnancies.92 The number of mortem cesarean section has resulted in maternal and neonatal cardiac deaths during pregnancy has increased steadily since survival.149 1991. The most common causes of maternal death from cardiac disease are myocardial infarction, followed by aortic dissec- Anesthetic Complications tion.92 A study completed in California also found that the Anesthesia-related maternal morbidity and mortality continue to incidence of myocardial infarction in pregnancy increased be a major concern, which has led to development of specialized throughout the 1990s.137 In addition, a nationwide review of obstetric anesthesia techniques.118 Cardiac arrest may result myocardial infarction in pregnancy in the United States found from spinal shock as a result of regional anesthesia. Induction of that the risk of myocardial infarction in pregnancy is 3 to 4 times general anesthesia may lead to loss of airway control or that of nonpregnant women of reproductive age.138 pulmonary aspiration, and emergence from anesthesia can be Women are deferring pregnancy to older ages, increasing the associated with hypoventilation or airway obstruction, leading to chance that they will have atherosclerotic heart disease. Because cardiac arrest.150 –155 Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 10. Vanden Hoek et al Part 12: Cardiac Arrest in Special Situations S837 Maternal Cardiac Arrest Not Immediately described in 1986 and has been perpetuated in specialty guide- Reversed by BLS and ACLS lines.143,166 The rescue team is not required to wait 5 minutes Emergency Cesarean Section in Cardiac Arrest before initiating emergency hysterotomy, and there are cir- Resuscitation team leaders should activate the protocol for an cumstances that support an earlier start.157 For instance, in an emergency cesarean delivery as soon as cardiac arrest is identi- obvious nonsurvivable injury,166,167–169 when the maternal fied in a pregnant woman with an obviously gravid uterus. By prognosis is grave and resuscitative efforts appear futile, the time the physician is ready to deliver the baby, standard moving straight to an emergency cesarean section may be ACLS should be underway and immediately reversible causes of appropriate, especially if the fetus is viable. cardiac arrest should be ruled out. When the gravid uterus is Many reports document long intervals between an urgent large enough to cause maternal hemodynamic changes due to decision for hysterotomy and actual delivery of the infant, far aortocaval compression, emergency cesarean section should be exceeding the obstetric guideline of 30 minutes for patients not considered, regardless of fetal viability. in arrest.170,171 Very few cases of perimortem cesarean section fall within the recommended 5-minute period.94,166 Survival of What Defines a Gravid Uterus With the Potential to the mother has been reported with perimortem cesarean section Cause Aortocaval Compression? performed up to 15 minutes after the onset of maternal cardiac A study found that maternal aortocaval compression can occur arrest.94,172–174 If emergency cesarean section cannot be per- for singleton pregnancies at 20 weeks of gestational age.156 formed by the 5-minute mark, it may be advisable to prepare to However, the exact gestational age at which aortocaval com- evacuate the uterus while the resuscitation continues. (Class IIb, pression occurs is not consistent, especially with multiple- LOE C). gestation pregnancies or intrauterine growth retardation, and At 24 to 25 weeks of gestation, the best survival rate for the gestational age and number of fetuses may not always be known infant occurs when the infant is delivered no more than 5 in the emergency situation. Fundal height is often used to minutes after the mother’s heart stops beating.175–178 Typically estimate gestational age. In a singleton gestation, by 20 weeks this requires that the provider begin the hysterotomy about 4 fundal height is approximately at the level of the umbilicus157; minutes after cardiac arrest. At gestational ages 30 weeks, however the fundus may reach the umbilicus between 15 and 19 infant survival has been seen even when delivery occurred after weeks of gestation.158 Fundal height may also be skewed by 5 minutes from onset of maternal cardiac arrest.166 In a recent other factors such as abdominal distention157 and increased body retrospective cohort series, neonatal survival was documented mass index; therefore fundal height may be a poor predictor of when delivery occurred within 30 minutes after onset of mater- gestational age. nal cardiac arrest.94 One review of emergency cesarean sections in maternal When there is an obvious gravid uterus, the emergency cardiac arrest before the third trimester concluded that if the cesarean section team should be activated at the onset of fundus extends above the level of the umbilicus, aortocaval maternal cardiac arrest (Class I, LOE B). Emergency cesarean compression can occur, and emergency cesarean section should section may be considered at 4 minutes after onset of maternal be performed regardless of gestational age.158 cardiac arrest if there is no return of spontaneous circulation Two cases of maternal cardiac arrest in early pregnancy of 13 (Class IIb, LOE C). to 15 weeks were reported in which the mother was resuscitated without an emergency cesarean section being performed and the Institutional Preparation for Maternal pregnancy continued to successful delivery of a live infant at Cardiac Arrest term.159,160 Not every pregnant woman in cardiac arrest is a Experts and organizations have emphasized the importance candidate for an emergency cesarean section; the decision of preparation.143,179 Providers at medical centers must depends on whether or not the gravid uterus is thought to review whether performance of an emergency hysterotomy interfere with maternal hemodynamics. is feasible, and if so, they must identify the best means of accomplishing this procedure rapidly. Team planning Why Perform an Emergency Cesarean Section in should be done in collaboration with the obstetric, neona- Cardiac Arrest? Several case reports of emergency cesarean section in maternal tal, emergency, anesthesiology, intensive care, and cardiac cardiac arrest indicate a return of spontaneous circulation or arrest services (Class I, LOE C). improvement in maternal hemodynamic status only after the Post–Cardiac Arrest Care uterus has been emptied.94 –96,143,149,161–166 In a case series of 38 One case report showed that post– cardiac arrest hypothermia cases of perimortem cesarean section, 12 of 20 women for can be used safely and effectively in early pregnancy without whom maternal outcome was recorded had return of spontane- emergency cesarean section (with fetal heart monitoring), with ous circulation immediately after delivery. No cases of worsened favorable maternal and fetal outcome after a term delivery.159 No maternal status after cesarean section were reported.166 The cases in the literature have reported the use of therapeutic critical point to remember is that both mother and infant may die hypothermia with perimortem cesarean section. Therapeutic if the provider cannot restore blood flow to the mother’s heart.94 hypothermia may be considered on an individual basis after The Importance of Timing With Emergency cardiac arrest in a comatose pregnant patient based on current Cesarean Section recommendations for the nonpregnant patient (Class IIb, LOE The 5-minute window that providers have to determine if C). During therapeutic hypothermia of the pregnant patient, it is cardiac arrest can be reversed by BLS and ACLS was first recommended that the fetus be continuously monitored for Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 11. S838 Circulation November 2, 2010 bradycardia as a potential complication, and obstetric and effective in patients with cardiovascular instability as outlined neonatal consultation should be sought (Class I, LOE C). below. Current BLS and ACLS should be used to manage cardiac arrest associated with all electrolyte disturbances. Part 12.4: Cardiac Arrest in the Morbidly Obese Potassium (K ) Morbid obesity can provide challenges during the resuscitation Potassium is maintained mainly in the intracellular compartment attempt. Airway management may be more challenging, and through the action of the Na /K ATPase pump. The magni- changes to the thorax may make resuscitative efforts more tude of the potassium gradient across cell membranes deter- demanding. Evidence from 2 case studies,180,181 1 case series,182 mines excitability of nerve and muscle cells, including the and 1 related clinical study183 indicated no differences in myocardium. survival based on patient weight. However, one large case series Potassium is tightly regulated. Under normal conditions po- demonstrated lower survival for morbidly obese children who tential differences across membranes, especially cardiac, are not required in-hospital pediatric CPR.184 affected by alterations in potassium level. Rapid or significant changes in serum concentrations of potassium result from the BLS and ACLS Modifications shifting of potassium from one space to another and may have No modifications to standard BLS or ACLS care have been life-threatening consequences. proven efficacious, although techniques may need to be adjusted due to the physical attributes of individual patients. Hyperkalemia Hyperkalemia is one of the few potentially lethal electrolyte Part 12.5: Cardiac Arrest Associated With disturbances. Severe hyperkalemia (defined as a serum potas- Pulmonary Embolism Pulmonary embolism (PE) can result in cardiovascular collapse sium concentration 6.5 mmol/L) occurs most commonly from and cardiac arrest. Although cardiac arrest caused by PE often renal failure or from release of potassium from cells and can presents as pulseless electric activity (PEA), not all cases of PEA cause cardiac arrhythmias and cardiac arrest. In 1 retrospective are caused by PE. in-hospital study of 29 063 patients, hyperkalemia was found to be directly responsible for sudden cardiac arrest in 7 cases.199 ACLS Modifications Acute kidney injury was present in all the arrest cases, accom- In patients with cardiac arrest and without known PE, routine panied by acute pancreatitis in 3 cases and acute hepatic failure fibrinolytic treatment given during CPR shows no benefit185,186 in 2 cases. Overall renal failure and drug treatment were the most and is not recommended (Class III, LOE A). common causes of hyperkalemia, with the most severe cases In patients with cardiac arrest and presumed PE, however, the occurring when excessive IV potassium was administered to a use of fibrinolytics during CPR may improve the patient’s patient with renal insufficiency. chance of survival.187–194 Despite the potential to increase the Although severe hyperkalemia may cause flaccid paralysis, risk of severe bleeding, fibrinolytics may improve survival to paresthesia, depressed deep tendon reflexes, or respiratory dif- discharge and long-term neurological function in patients with ficulties,200 –202 the first indicator of hyperkalemia may be the presumed PE-induced cardiac arrest.193–196 Emergency echocar- presence of peaked T waves (tenting) on the electrocardiogram diography may be helpful in determining the presence of (ECG). As serum potassium rises, the ECG may progressively thrombus or PE. develop flattened or absent P waves, a prolonged PR interval, In a small number of patients, percutaneous mechanical widened QRS complex, deepened S waves, and merging of S thromboembolectomy during CPR has been performed success- and T waves (Figure 5). If hyperkalemia is left untreated, a fully.189 Surgical embolectomy has also been used successfully sine-wave pattern, idioventricular rhythms, and asystolic cardiac in some patients with PE-induced cardiac arrest.191,197,198 arrest may develop.203,204 In patients with cardiac arrest due to presumed or known PE, it is reasonable to administer fibrinolytics (Class IIa, LOE B). ACLS Modifications in Management of Severe Survival has been described with percutaneous mechanical Cardiotoxicity or Cardiac Arrest Due to Hyperkalemia thrombectomy or surgical embolectomy with or without prior Treatment of severe hyperkalemia aims at protecting the heart treatment with fibrinolysis. from the effects of hyperkalemia by antagonizing the effect of potassium on excitable cell membranes, forcing potassium into Part 12.6: Cardiac Arrest Associated With cells to remove it promptly from the circulation, and removing Life-Threatening Electrolyte Disturbances potassium from the body. Therapies that shift potassium will act Electrolyte abnormalities can be associated with cardiovascular rapidly but are temporary and thus may need to be repeated. In emergencies and may cause or contribute to cardiac arrest, order of urgency, treatment includes the following: hinder resuscitative efforts, and affect hemodynamic recovery after cardiac arrest. An evidence-based review in 2010 focused Stabilize myocardial cell membrane: on electrolyte abnormalities most often associated with cardiac Calcium chloride (10%): 5 to 10 mL (500 to 1000 mg) arrest. IV over 2 to 5 minutes or calcium gluconate (10%): 15 Early consideration may be given to using selective methods to 30 mL IV over 2 to 5 minutes of therapeutic management in addition to standard ACLS pro- Shift potassium into cells: tocols that can be provided rapidly and have been shown to be Sodium bicarbonate: 50 mEq IV over 5 minutes Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 12. Vanden Hoek et al Part 12: Cardiac Arrest in Special Situations S839 pointes, is largely based on historical case reports that report slow infusion of potassium over hours.212 The effect of bolus administration of potassium for cardiac arrest suspected to be secondary to hypokalemia is unknown and ill advised (Class III, LOE C). Sodium (Na ) Sodium is the major intravascular ion that influences serum osmolality. Sodium abnormalities are unlikely to lead to cardiac arrest, and there are no specific recommendations for either checking or treating sodium during cardiac arrest. Disturbances in sodium level are unlikely to be the primary cause of severe cardiovascular instability. Magnesium (Mg ) Magnesium is an essential electrolyte and an important cofactor for multiple enzymes, including ATPase. Magnesium is neces- sary for the movement of sodium, potassium, and calcium into and out of cells and plays an important role in stabilizing excitable membranes. The presence of a low plasma magnesium concentration has been associated with poor prognosis in cardiac arrest patients.208,213–216 Hypermagnesemia Hypermagnesemia is defined as a serum magnesium concentra- tion 2.2 mEq/L (normal: 1.3 to 2.2 mEq/L). Neurological symptoms of hypermagnesemia include muscular weakness, paralysis, ataxia, drowsiness, and confusion. Hypermagnesemia Figure 5. ECG changes in hyperkalemia. can produce vasodilation and hypotension.217 Extremely high serum magnesium levels may produce a depressed level of Glucose plus insulin: mix 25 g (50 mL of D50) glucose consciousness, bradycardia, cardiac arrhythmias, hypoventila- and 10 U regular insulin and give IV over 15 to 30 tion, and cardiorespiratory arrest.208,215,216 minutes Nebulized albuterol: 10 to 20 mg nebulized over 15 ACLS Modifications in Management of Cardiac Arrest minutes and Severe Cardiotoxicity Due to Hypermagnesemia Promote potassium excretion: Administration of calcium (calcium chloride [10%] 5 to 10 mL Diuresis: furosemide 40 to 80 mg IV or calcium gluconate [10%] 15 to 30 mL IV over 2 to 5 minutes) Kayexalate: 15 to 50 g plus sorbitol per oral or per may be considered during cardiac arrest associated with hyper- rectum magnesemia (Class IIb, LOE C). Dialysis Hypomagnesemia When cardiac arrest occurs secondary to hyperkalemia, it may Hypomagnesemia, defined as a serum magnesium concentration be reasonable to administer adjuvant IV therapy as outlined 1.3 mEq/L, is far more common than hypermagnesemia. above for cardiotoxicity in addition to standard ACLS (Class IIb, Hypomagnesemia usually results from decreased absorption or LOE C). increased loss of magnesium from either the kidneys or intes- ACLS Modifications in Management of Severe tines (diarrhea). Alterations in thyroid hormone function, certain Cardiotoxicity Due to Hypokalemia medications (eg, pentamidine, diuretics, alcohol), and malnour- Life-threatening hypokalemia is uncommon but can occur in the ishment can also induce hypomagnesemia. setting of gastrointestinal and renal losses and is associated with ACLS Modifications in Management of Cardiac Arrest hypomagnesemia. Severe hypokalemia will alter cardiac tissue and Severe Cardiotoxicity Due to Hypomagnesemia excitability and conduction. Hypokalemia can produce ECG Hypomagnesemia can be associated with polymorphic ventric- changes such as U waves, T-wave flattening, and arrhythmias ular tachycardia, including torsades de pointes, a pulseless form (especially if the patient is taking digoxin), particularly ventric- (polymorphic) of ventricular tachycardia. For cardiotoxicity and ular arrhythmias,205,206 which, if left untreated, deteriorate to cardiac arrest, IV magnesium 1 to 2 g of MgSO4 bolus IV push PEA or asystole. is recommended (Class I, LOE C). Several studies reported an association with hypokalemia and development of ventricular fibrillation,207–210 whereas a single Calcium (Ca ) animal study reported that hypokalemia lowered the ventricular Calcium abnormality as an etiology of cardiac arrest is rare. fibrillation threshold.211 However, the management of hypoka- There are no studies evaluating the treatment of hypercalcemia lemia in the setting of cardiotoxicity, specifically torsades de or hypocalcemia during arrest. However, empirical use of Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 13. S840 Circulation November 2, 2010 calcium (calcium chloride [10%] 5 to 10 mL OR calcium who accompany the patient, evaluation of containers, review of gluconate [10%] 15 to 30 mL IV over 2 to 5 minutes) may be pharmacy records, and examination of the patient’s prior med- considered when hyperkalemia or hypermagnesemia is sus- ical record.220 Many patients who ingest medications in a suicide pected as the cause of cardiac arrest (Class IIb, LOE C). attempt take more than 1 substance, and the number of sub- stances ingested is greater in fatal than in nonfatal suicide Part 12.7: Cardiac Arrest Associated With attempts.221 Comprehensive toxicology laboratory testing is Toxic Ingestions virtually never available in a time frame that supports early Poisoning has been likened to trauma on the cellular level, resuscitation decisions.222 destroying the natural workings of a victim’s physiology.218 Poisoned patients may deteriorate rapidly. Care for all adult Severe poisoning alters the function of a cellular receptor, ion patients who are critically ill or under evaluation for possible channel, organelle, or chemical pathway to the extent that critical toxin exposure or ingestion, particularly when the history is organ systems can no longer support life. uncertain, should begin in a monitored treatment area where the As with any patient in cardiac arrest, management of the development of central nervous system depression, hemody- patient with a toxic exposure begins with support of airway, namic instability, or seizures can be rapidly recognized and breathing, and circulation. Cardiac arrest due to toxicity is addressed.223 managed in accordance with the current standards of BLS and Gastrointestinal decontamination, once a mainstay in the ACLS. With few exceptions, there are no unique antidotes or management of ingested toxins, has a less significant role in toxin-specific interventions that are recommended during resus- poisoning treatment today. With rare exceptions, gastric lavage, citation from cardiac arrest. whole bowel irrigation, and administration of syrup of ipecac are Once return of spontaneous circulation is achieved, urgent no longer recommended.224 –226 Administration of single-dose consultation with a medical toxicologist or certified regional activated charcoal to adsorb ingested toxins is generally recom- poison center is recommended, as the postarrest management of mended for the ingestion of life-threatening poisons for which the critically poisoned patient may benefit from a thorough no adequate antidotal therapy is available and when the charcoal understanding of the toxic agent. Consultation is also recom- can be administered within 1 hour of poisoning.228 Multiple- mended early in the management of a patient with potentially dose activated charcoal should be considered for patients who life-threatening poisoning, when appropriate interventions might have ingested a life-threatening amount of specific toxins (eg, prevent deterioration to cardiac arrest. In the United States a carbamazepine, dapsone, phenobarbital, quinine, or theophyl- certified poison center can be reached by calling 1-800-222- line) for which a benefit of this strategy has been established.229 1222; in Canada, call 1-800-268-9017. Charcoal should not be administered for ingestions of caustic It is extremely difficult to conduct clinical trials of acute substances, metals, or hydrocarbons.228 life-threatening poisoning. Challenges include the infrequency Charcoal should only be administered to patients with an with which most specific conditions occur, the heterogeneity of intact or protected airway. In patients who are at risk for presentation, and ethical challenges related to withholding es- aspiration, endotracheal intubation and head-of-bed elevation tablished care from patients who are unable to provide informed should be performed before charcoal administration.229,230 Be- consent because the patient has an altered mental status, the cause the decision to perform gastrointestinal decontamination is patient is suicidal, or there is a lack of time to explain treatment complex, multifactorial, and associated with risk, expert advice alternatives.219 can be helpful. The majority of questions addressing cardiac arrest due to drug toxicity remain unanswered. Epidemiological studies are Toxidromes required to document the incidence rate of cardiac arrests A “toxidrome” is a clinical syndrome—a constellation of signs, secondary to drug toxicity and the safety and efficacy baseline symptoms, and laboratory findings—suggestive of the effects of rates for current therapeutic strategies. This section presents a specific toxin. By recognizing these presentations, the clinician recommendations for the care of the patient with a toxicological can establish a working diagnosis that guides initial manage- problem causing cardiac arrest or severe cardiovascular instabil- ment. Some common toxidromes are presented in the Table. ity (respiratory depression, hypotension, life-threatening alter- Practically every sign and symptom observed in poisoning ations of cardiac conduction, etc). Some recommendations are can be produced by natural disease, and many clinical evidence-based, but most research in this area consists of case presentations associated with natural disease can be mim- reports, small case series, animal studies, and pharmacokinetic icked by some poison.231 It is important to maintain a studies in healthy volunteers. Virtually no toxicology research broad differential diagnosis, particularly when the history involves human cardiac arrest. Thus, many of these recommen- of toxic chemical exposure is unclear. dations are based on expert consensus, and further research is needed to validate them. Opioid Toxicity There are no data to support the use of specific antidotes in the Initial Approach to the Critically Poisoned Patient setting of cardiac arrest due to opioid overdose. Resuscitation Management of the critically poisoned patient begins with from cardiac arrest should follow standard BLS and ACLS airway protection, support of respiration and circulation, and algorithms. rapid assessment. Patients may or may not be able to provide an Naloxone is a potent antagonist of the binding of opioid accurate history of exposure to a toxic substance. Whenever medications to their receptors in the brain and spinal cord. possible, history gathering should include questioning of persons Administration of naloxone can reverse central nervous system Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011
  • 14. Vanden Hoek et al Part 12: Cardiac Arrest in Special Situations S841 Table. Common Toxidromes* Benzodiazepines Cardiac Signs There are no data to support the use of specific antidotes in the setting of cardiac arrest due to benzodiazepine overdose. Resus- Tachycardia and/or Bradycardia and/or Cardiac Conduction citation from cardiac arrest should follow standard BLS and Hypertension Hypotension Delays (Wide QRS) ACLS algorithms. Amphetamines Beta blockers Cocaine Flumazenil is a potent antagonist of the binding of benzodi- Anticholinergic drugs Calcium channel Cyclic antidepressants azepines to their central nervous system receptors. Administra- blockers tion of flumazenil can reverse central nervous system and Antihistamines Clonidine Local anesthetics respiratory depression caused by benzodiazepine overdose. Cocaine Digoxin and related Propoxyphene Flumazenil has no role in the management of cardiac arrest. glycosides The administration of flumazenil to patients with undifferen- Theophylline/caffeine Organophosphates Antiarrhythmics (e.g., tiated coma confers risk and is not recommended (Class III, LOE and carbamates quinidine, flecainide) B). Flumazenil administration can precipitate seizures in Withdrawal states benzodiazepine-dependent patients and has been associated with seizures, arrhythmia, and hypotension in patients with co- CNS/Metabolic Signs ingestion of certain medications, such as tricyclic antidepres- CNS and/or Respiratory sants.247,248 However, flumazenil may be used safely to Seizures Depression Metabolic Acidosis reverse excessive sedation known to be due to the use of Antidepressants benzodiazepines in a patient without known contraindications Cyclic antidepressants (several classes) Cyanide (eg, procedural sedation).249 Isoniazid Benzodiazepines Ethylene glycol Selective and non-selective -Blockers norepinephrine reuptake There are no data to support the use of specific antidotes in the inhibitors (eg, bupropion) Carbon monoxide Metformin setting of cardiac arrest due to -blocker overdose. Resuscitation Withdrawal states Ethanol Methanol from cardiac arrest should follow standard BLS and ACLS Methanol Salicylates algorithms. Opioids -Blocker medication overdose may cause such severe inhi- Oral hypoglycemics bition of -adrenergic receptors that high-dose vasopressors *Differential diagnosis lists are partial. cannot effectively restore blood pressure, cardiac output, or perfusion. Therapeutic options in the treatment of refractory hemodynamic instability due to -blocker overdose include and respiratory depression caused by opioid overdose. Naloxone administration of glucagon, high-dose insulin, or IV calcium has no role in the management of cardiac arrest. In the patient with known or suspected opioid overdose with salts. respiratory depression who is not in cardiac arrest, ventilation Glucagon should be assisted by a bag mask,232–238 followed by adminis- Administration of glucagon may be helpful for severe cardio- tration of naloxone and placement of an advanced airway if there vascular instability associated with -blocker toxicity that is is no response to naloxone (Class I, LOE A). refractory to standard measures, including vasopressors. The Administration of naloxone can produce fulminate opioid recommended dose of glucagon is a bolus of 3 to 10 mg, withdrawal in opioid-dependent individuals, leading to agitation, administered slowly over 3 to 5 minutes, followed by an infusion hypertension, and violent behavior. For this reason, naloxone of 3 to 5 mg/h (0.05 to 0.15 mg/kg followed by an infusion of administration should begin with a low dose (0.04 to 0.4 mg), 0.05 to 0.10 mg/kg per hour) (Class IIb, LOE C).250 –262 The with repeat dosing or dose escalation to 2 mg if the initial infusion rate is titrated to achieve an adequate hemodynamic response is inadequate.239 Some patients may require much response (appropriate mean arterial pressure and evidence of higher doses to reverse intoxication with atypical opioids, such good perfusion). Because the amount of glucagon required to as propoxyphene, or following massive overdose inges- sustain this therapy may exceed 100 mg in a 24-hour period, tions.240,241 Naloxone can be given IV,235,236,242,243 IM,232,235,236 plans should be made early to ensure that an adequate supply of intranasally,232,242 and into the trachea.244 glucagon is available. Glucagon commonly causes vomiting. In The duration of action of naloxone is approximately 45 to 70 patients with central nervous system depression, the airway must minutes, but respiratory depression caused by ingestion of a be protected before glucagon administration. Animal studies long-acting opioid (eg, methadone) may last longer. Thus, the have suggested that the concomitant use of dopamine alone or in clinical effects of naloxone may not last as long as those of the combination with isoproterenol and milrinone may decrease the opioid, and repeat doses of naloxone may be needed. effectiveness of glucagon.263–265 Patients with life-threatening central nervous system or respi- ratory depression reversed by naloxone administration should be Insulin observed for resedation. Although a brief period of observation Animal studies suggest that high-dose IV insulin, accompanied may be appropriate for patients with morphine or heroin over- by IV dextrose supplementation and electrolyte monitoring, may dose,245 a longer period of observation may be required to safely improve hemodynamic stability and survival in -blocker over- discharge a patient with life-threatening overdose of a long- dose by improving myocardial energy utilization.266,267 A single acting or sustained-release opioid.239,246 human case report268 showed improved hemodynamic stability Downloaded from http://circ.ahajournals.org/ at VA MED CTR BOISE on September 29, 2011